{
  "meta": {
    "title": "Biochemistry_Test",
    "url": "https://brainandscalpel.vercel.app/biochemistry-test-fb528530.html",
    "scrapedAt": "2025-11-30T12:48:21.701Z"
  },
  "questions": [
    {
      "text": "A patient with deafness and mental retardation is found to have an excess accumulation of glycosaminoglycans in his body. After a detailed evaluation, he is diagnosed with Hunter disease. What is the site of synthesis of these accumulated substances?",
      "choices": [
        {
          "id": 1,
          "text": "Mitochondria and Golgi apparatus"
        },
        {
          "id": 2,
          "text": "Endoplasmic reticulum and Golgi apparatus"
        },
        {
          "id": 3,
          "text": "Lysosomes and endoplasmic reticulum"
        },
        {
          "id": 4,
          "text": "Endoplasmic reticulum and mitochondria"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The sites of synthesis of glycosaminoglycans (GAG) are the endoplasmic reticulum and Golgi apparatus.</p>\n<p>Synthesis of the core proteins occurs in the <strong>endoplasmic reticulum,</strong> whereas, biosynthesis of <strong>glycosaminoglycan chains</strong> and their subsequent modifications occurs in the <strong>Golgi apparatus</strong></p>\n<p>Glycosaminoglycans or mucopolysaccharides are complex carbohydrates made up of <strong>amino sugars</strong> and <strong>uronic acids.</strong> They may be attached to a protein molecule to form a proteoglycan. Proteoglycans are components of the ground substance of connective tissue. Proteoglycans have a <strong>bottle brush appearance.</strong></p>\n<p>Note: <strong>Hyaluronic acid</strong> is the only GAG that is not synthesized by the <strong>Golgi apparatus.</strong> It is formed at the <strong>plasma membrane.</strong> It participates in cellular migration among other things.</p><hr><h3>Related Pearl: MPS and Their Respective Enzyme Deficiencies</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br />Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>&alpha;-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br />Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br />coarse facial features,&nbsp;<br />Hepatosplenomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br />Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br />Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>&alpha;-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>&alpha;-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br />short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>&beta;-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br />Short stature<br />Skeletal dysplasia<br />Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>&beta;-glucuronidase</td>\n<td>Dermatan sulfate<br />Heparan sulfate<br />Chondroitin 4-sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;<br /><br /></td>\n<td>Short stature<br />Skeletal dysplasia<br />Hepatomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br />Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1451",
      "difficulty": "medium"
    },
    {
      "text": "A 6-year-old mentally retarded girl presents with a protuberant abdomen, short stature, coarse facial features, and cloudy corneas. Skeletal malformations include dysostosis multiplex and bullet-shaped middle phalanx. Which of the following enzyme deficiencies is most likely in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Iduronate sulfatase"
        },
        {
          "id": 2,
          "text": "β-Galactosidase"
        },
        {
          "id": 3,
          "text": "α-L-Iduronidase"
        },
        {
          "id": 4,
          "text": "β-Glucuronidase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical features point to the diagnosis of <strong>Hurler's disease</strong> (MPS 1). Deficiency of the enzyme <strong>α-L-iduronidase</strong> that degrades glycosaminoglycans results in Hurler’s disease.</p>\n<p><strong>Hurler’s disease </strong>was also known previously as <strong>gargoylism</strong> (coarse facial features).</p>\n<p>Clinical features of the disease include <strong>coarse facial features, corneal clouding,</strong> large tongue, and inguinal hernias. They also present with <strong>hepatosplenomegaly,</strong> short stature, skeletal dysplasia, and can present with <strong>hydrocephalus</strong> or <strong>valvular heart disease.</strong> These patients also have <strong>Reilly body inclusions</strong> in their <strong>leukocytes.</strong> </p>\n<p>The gene encoding α-L-iduronidase is present on <strong>chromosome 4</strong>. Heparan sulfate and dermatan sulfate are accumulated. Enzyme replacement therapy is available in the form of <strong>aldurazyme</strong>.</p>\n<p><strong>Mucopolysaccharidoses</strong> are a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans.</p>\n<ul>\n<li><strong>Most common MPS</strong>: Sanfilippo &gt;  Hunter’s and Hurler’s </li>\n<li><strong>MPS with no mental retardation</strong>: Scheie’s disease, Morquio syndrome, and Maroteaux–Lamy syndrome.</li>\n<li><strong>MPS with no corneal clouding:</strong> Hunter’s disease and Sanfilippo syndrome</li>\n<li><strong>MPS with XLR inheritance:</strong> Hunter’s disease</li>\n<li><strong>MPS with no visceromegaly:</strong> Morquio’s disease</li>\n<li>Skeletal deformity associated with all MPS: Dysostosis multiplex</li>\n<li><strong>MPS with no leucocyte inclusions:</strong> Morquio’s disease</li>\n</ul><hr><h3>Related Pearl: MPS and Their Respective Enzyme Deficiencies</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br />Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>&alpha;-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br />Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br />coarse facial features,&nbsp;<br />Hepatosplenomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br />Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br />Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>&alpha;-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>&alpha;-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br />short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>&beta;-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br />Short stature<br />Skeletal dysplasia<br />Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>&beta;-glucuronidase</td>\n<td>Dermatan sulfate<br />Heparan sulfate<br />Chondroitin 4-sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;<br /><br /></td>\n<td>Short stature<br />Skeletal dysplasia<br />Hepatomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br />Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1467",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are enantiomers?",
      "choices": [
        {
          "id": 1,
          "text": "D-galactose and L-fructose"
        },
        {
          "id": 2,
          "text": "Galactose and glucose"
        },
        {
          "id": 3,
          "text": "D-mannose and L-mannose"
        },
        {
          "id": 4,
          "text": "D-glucose and D-mannose"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>D-mannose</strong> and<strong> L-mannose</strong> are<strong> enantiomers. </strong>Enantiomers are mirror images of each other.</p>\n<p>The designation of a sugar isomer as the D- or L- form is determined by its spatial relationship to the parent compound of the carbohydrates, that is, the three-carbon sugar glyceraldehyde. The orientation of the —H and —OH groups around the penultimate carbon atom determines whether the sugar belongs to the D- or L- series. When the <strong>—OH group</strong> on the <strong>penultimate carbon</strong> atom of the sugar is on the <strong>right side</strong>, then the sugar is designated as a <strong>D</strong>- <strong>isomer</strong>. When the <strong>–OH group is on the left</strong>, it is an <strong>L-isomer</strong>.</p>\n<p>Naturally occurring <strong>monosaccharides</strong> are<strong> D-sugars </strong>and naturally occurring <strong>amino acids </strong>are <strong>L-isomers. Racemase</strong> enzyme <strong>interconverts</strong> between D and L isomers.</p>\n<p>Examples of enantiomers include D-glucose and L-glucose, D-fructose and L-fructose and D-mannose and L-mannose</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9e4322598f9f496387dceafdb63480cdx1280x1147.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1447",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following substances inhibits the rate-limiting enzyme in glycolysis?",
      "choices": [
        {
          "id": 1,
          "text": "AMP"
        },
        {
          "id": 2,
          "text": "Glucose-6-PO4"
        },
        {
          "id": 3,
          "text": "Citrate"
        },
        {
          "id": 4,
          "text": "Insulin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Phosphofructokinase (PFK-1)</strong> is the <strong>rate-limiting</strong> enzyme in glycolysis. <strong>Citrate inhibits</strong> the PFK-1.</p>\n<p><strong>Mg2+</strong> serves as the co-factor for the enzyme. This step is the <strong>committed</strong> step of glycolysis.</p>\n<p>In general, end products of a reaction on accumulation can inhibit the forward direction progress of any reaction. Substrates and cofactors of an enzyme/reaction will stimulate a reaction/to activate the enzyme, and hence push the reaction in the forward direction.</p>\n<p><strong>Inhibitors</strong> of PFK-1: ATP, Citrate</p>\n<p>Allosteric <strong>activators </strong>of PFK-1: AMP, ADP, <strong>Fructose 2,6 bisphosphate</strong> (<strong>Most potent activator</strong>)</p>\n<p><strong>Hormonal</strong> regulation: Inducer — <strong>Insulin,</strong> Repressor— Glucagon</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c999483a311244b0ae9c8e60c5750ad4x1280x2966.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Rate determining enzymes and their key regulators</h3><table>\n<tbody>\n<tr>\n<td>Pathway</td>\n<td>Enzyme&nbsp;</td>\n<td>Regulating factors</td>\n</tr>\n<tr>\n<td>Glycolysis</td>\n<td>Phosphofructokinase (PFK-1)</td>\n<td>\n<p>AMP+, Fructose 2,6 bi-phosphate+</p>\n<p>ATP-, Citrate-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;gluconeogenesis</td>\n<td>Fructose-1,6-bisphosphatase</td>\n<td>\n<p>ATP+, Acetyl CoA+</p>\n<p>AMP-, Fructose 2,6 bi-phosphate-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Krebs cycle</td>\n<td>Isocitrate dehydrogenase</td>\n<td>\n<p>ADP+,</p>\n<p>ATP-, NADH-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;glycogenesis</td>\n<td>Glycogen synthase</td>\n<td>\n<p>Glucose-6-phosphate+, insulin+, cortisol+,</p>\n<p>Epinephrine-, glucagon-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;glycogenolysis</td>\n<td>Glycogen phosphorylase</td>\n<td>\n<p>Epinephrine+, glucagon+, AMP+</p>\n<p>Glucose-6-phosphate-, insulin-, ATP-</p>\n</td>\n</tr>\n<tr>\n<td>HMP shunt&nbsp;</td>\n<td>Glucose-6-phosphate dehydrogenase (G6PD)</td>\n<td>\n<p>NADP+</p>\n<p>NADPH-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Denovo pyrimidine synthesis</td>\n<td>Carbamoyl phosphate synthetase II</td>\n<td>\n<p>ATP+</p>\n<p>UTP-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Denovo purine synthesis</td>\n<td>Glutamine-phosphoribosylpyrophosphate (PRPP) amidotransferase</td>\n<td>AMP-, IMP-, GMP-</td>\n</tr>\n<tr>\n<td>&nbsp;Urea cycle</td>\n<td>Carbamoyl phosphate synthetase I</td>\n<td>N-acetyl glutamate (NAG)+</td>\n</tr>\n<tr>\n<td>&nbsp;Fatty acid synthesis</td>\n<td>Acetyl-CoA carboxylase (ACC)</td>\n<td>\n<p>Insulin+, citrate+</p>\n<p>Glucagon-, palmitoyl-CoA-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Fatty acid oxidation</td>\n<td>Carnitine acyltransferase I</td>\n<td>Malonyl-CoA-</td>\n</tr>\n<tr>\n<td>&nbsp;Cholesterol synthesis</td>\n<td>HMG-CoA reductase</td>\n<td>\n<p>Insulin+, thyroxine+</p>\n<p>Glucagon-, cholesterol-</p>\n</td>\n</tr>\n<tr>\n<td>Ketogenesis</td>\n<td>HMG-CoA synthase</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>+ Positive effect on the pathway.</p>\n<p>- Negative effect on the pathway.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0058",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a substrate for gluconeogenesis?",
      "choices": [
        {
          "id": 1,
          "text": "Glucogenic amino acids"
        },
        {
          "id": 2,
          "text": "Propionate"
        },
        {
          "id": 3,
          "text": "Glycerol"
        },
        {
          "id": 4,
          "text": "Acetyl CoA"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Acetyl CoA</strong> is not a substrate for gluconeogenesis. Instead, it enters the<strong> Krebs cycle</strong> for<strong> oxidative phosphorylation.</strong></p>\n<p>The following serve as substrates for gluconeogenesis:</p>\n<ul>\n<li><strong>Glucogenic amino acids</strong>, alanine being the major contributor (alanine is the source of pyruvate). Glucogenic amino acids are converted into pyruvate, oxaloacetate, succinyl CoA, and alpha-ketoglutarate to enter gluconeogenesis and the Krebs cycle at various points.</li>\n<li>Lactate</li>\n<li>Pyruvate</li>\n<li><strong>Glycerol</strong></li>\n<li><strong>Propionate</strong> (ruminants)</li>\n</ul><hr><h3>Related Pearl: Amino Acid Classification Based on Metabolism (Glucogenic/Ketogenic ) and Nutritional requirement (Essential/Non essential)</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Glucogenic</strong></p>\n</td>\n<td>\n<p><strong>Ketogenic</strong></p>\n</td>\n<td>\n<p><strong>Both</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Non-essential</p>\n</td>\n<td>\n<p>Alanine</p>\n<p>Arginine (semi-essential)</p>\n<p>Asparagine</p>\n<p>Aspartate</p>\n<p>Cysteine</p>\n<p>Glutamate</p>\n<p>Glutamine</p>\n<p>Glycine</p>\n<p>Proline</p>\n<p>Serine</p>\n</td>\n<td>&nbsp;</td>\n<td>Tyrosine</td>\n</tr>\n<tr>\n<td>\n<p>Essential</p>\n</td>\n<td>\n<p>Histidine</p>\n<p>Methionine</p>\n<p>Valine</p>\n<p>Threonine</p>\n</td>\n<td>\n<p>Leucine</p>\n<p>Lysine</p>\n</td>\n<td>\n<p>Isoleucine</p>\n<p>Phenylalanine</p>\n<p>Tryptophan</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0443",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not seen in low insulin-glucagon ratio ________.",
      "choices": [
        {
          "id": 1,
          "text": "Glycogen breakdown"
        },
        {
          "id": 2,
          "text": "Ketogenesis"
        },
        {
          "id": 3,
          "text": "Glycogen storage"
        },
        {
          "id": 4,
          "text": "Gluconeogenesis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Low-insulin/glucagon ratio indicates low insulin and high glucagon levels, which are observed in the&nbsp;fasting state. In the fasting state, all of the above processes (i.e., glycogen breakdown, ketogenesis, and gluconeogenesis) occur, but not glycogen storage.</p>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Metabolic process</strong></p>\n</td>\n<td>\n<p><strong>Fasting state/ low insulin-glucagon ratio</strong></p>\n</td>\n<td>\n<p><strong>Fed state/ high insulin-glucagon ratio </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluconeogenesis</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glycogenolysis</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ketogenesis</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glycogen storage</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1484",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following pairs correctly represents the primary glycosidic bond linkage and the branch-point bond linkage in glycogen, respectively?",
      "choices": [
        {
          "id": 1,
          "text": "α(1→4) linkage; α(1→6) linkage"
        },
        {
          "id": 2,
          "text": "α (1→6) linkage; α (1→4) linkage"
        },
        {
          "id": 3,
          "text": "α (1→4) linkage; α (1→4) linkage"
        },
        {
          "id": 4,
          "text": "α (1→6) linkage; α(1→6) linkage"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In <strong>glycogen,</strong> the <strong>primary glycosidic bond</strong> is an <strong>α (1→4) linkage,</strong> whereas the <strong>branch point</strong> contains an <strong>α (1→6) linkage.</strong></p>\n<p>Glycogen is a branched-chain homopolysaccharide with α-D-glucose being the monosaccharide, its major constituent.</p><hr><h3>Related Pearl: Structural Bond of Various Polysaccharides</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Polysaccharides</strong></p>\n</td>\n<td>\n<p><strong>Structure</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Amylose starch</p>\n</td>\n<td>\n<p>Unbranched chain, &alpha; (1&rarr;4) glycosidic&nbsp; linkages of glucose. Hollow helix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Amylopectin&nbsp; starch</p>\n</td>\n<td>\n<p>&alpha; (1&rarr;4) glycosidic linkages with &alpha; (1&rarr;6) glycosidic branches every 24-30 glucose molecule. Hollow helix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glycogen</p>\n</td>\n<td>\n<p>&alpha; (1&rarr;4) glycosidic linkages with &alpha; (1&rarr;6) glycosidic branches every 8-12 glucose molecule. Hollow helix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cellulose</p>\n</td>\n<td>\n<p>Unbranched beta (1&rarr;4) glycosidic linkages of glucose. Linear</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chitin</p>\n</td>\n<td>\n<p>Unbranched beta (1&rarr;4) glycosidic linkages of N-acetylglucosamine. Linear</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e524177809ef4294bcfeb64714a90170x1280x442.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1670",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is a primer acting as an acceptor of glucose residues in the process of glycogen synthesis?",
      "choices": [
        {
          "id": 1,
          "text": "Protein"
        },
        {
          "id": 2,
          "text": "Carbohydrate"
        },
        {
          "id": 3,
          "text": "Lipid"
        },
        {
          "id": 4,
          "text": "Nucleic acid"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A protein named <strong>glycogenin</strong> is the primer acting as an <strong>acceptor</strong> of <strong>glucose residues</strong> in the process of <strong>glycogen synthesis.</strong></p>\n<p>The ensuing entity is glycosylated further by UDP-glucose. Glycogenin further <strong>catalyzes</strong> the transfer of <strong>seven glucose residues</strong> from <strong>UDP-Glucose,</strong> in 1 → 4 linkages, to form a <strong>glycogen primer.</strong> This in turn serves as the substrate for the enzyme, <strong>glycogen synthase,</strong> which is the rate-limiting enzyme of glycogen synthesis.</p><hr><h3>Related Pearl: Steps in Glycogenesis & Respective Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Steps</strong></p>\n</td>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose Phosphorylation</p>\n</td>\n<td>\n<p>Hexokinase&nbsp;in Muscle</p>\n<p>Glucokinase&nbsp;in Liver</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose-6-PO4 to Glucose-1-PO4 conversion</p>\n</td>\n<td>\n<p>Phosphoglucomutase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Attachment of UTP to Glucose-1-PO4</p>\n</td>\n<td>\n<p>UDP Glucose Pyrophosphorylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Attachment of UDP-Glucose to Glycogen Primer (Glycogenin)</p>\n</td>\n<td>\n<p>Glycogen initiator synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glycogen synthesis</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glycogen Branches formation</p>\n</td>\n<td>\n<p>Branching enzyme (amylo-[1&mdash;4]&mdash;&gt;[1&mdash;6]-transglucosidase)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1676",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following vitamins serves as the cofactor of the enzyme glycogen phosphorylase?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B1"
        },
        {
          "id": 2,
          "text": "Vitamin B6"
        },
        {
          "id": 3,
          "text": "Vitamin B2"
        },
        {
          "id": 4,
          "text": "VItamin B7"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Glycogen phosphorylase</strong> requires <strong>pyridoxal phosphate,</strong> i.e., <strong>vitamin B6</strong>, as its coenzyme.</p>\n<p>The process of phosphorolytic cleavage of the 1 → 4 linkages of glycogen to yield single units of glucose 1-phosphate, is catalyzed by the enzyme glycogen phosphorylase.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1686",
      "difficulty": "easy"
    },
    {
      "text": "An adolescent male patient presented with pain in the calf muscles on exercise. On biopsy, an excessive amount of glycogen was found to be present in the muscle. What is the most likely enzyme deficiency?",
      "choices": [
        {
          "id": 1,
          "text": "Muscle-debranching enzyme"
        },
        {
          "id": 2,
          "text": "Phosphofructokinase 1"
        },
        {
          "id": 3,
          "text": "Glucose 6 phosphatase"
        },
        {
          "id": 4,
          "text": "Muscle glycogen phosphorylase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical features are seen in <strong>McArdle's disease.</strong> This patient has <strong>muscle glycogen phosphorylase</strong> <strong>deficiency.</strong></p>\n<p>The lack of muscle glycogen phosphorylase results in <strong>excess glycogen</strong> build-up in muscles. The image given below shows the vacuolar myopathy seen in McArdle's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/86d16fb179ed440db5df3a0963d550bcx1280x948.JPEG\" alt=\"Explanation Image\"><p>Clinical features include <strong>poor exercise</strong> tolerance, abnormally <strong>high muscle glycogen</strong> (2.5-4%), and a very <strong>low blood lactate</strong> after exercise</p>\n<p>The images given below show myophosphorylase enzyme histochemistry showing (A) Normal muscle and (B) McArdle's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8296f8ac047546f2b52c591a7d639613x1280x841.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Glycogen Storage Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p><strong>Von Gierke's disease</strong></p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierke's disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p><strong>Pompe's disease</strong></p>\n</td>\n<td>\n<p>Lysosomal &alpha;1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~ 2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p><strong>Cori's/Forbes disease</strong></p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched-chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n<p>Normal lactate and uric acid levels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p><strong>Andersen disease</strong></p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharides with few branch points</p>\n<p>Death at age ~ 5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p><strong>McArdle disease</strong></p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p><strong>Her's disease</strong></p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p><strong>Tarui's disease</strong></p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5236",
      "difficulty": "medium"
    },
    {
      "text": "To assess the vitamin B1 nutritional status in a patient, measurement of which of the following can be used?",
      "choices": [
        {
          "id": 1,
          "text": "Glucose-6-phosphate dehydrogenase"
        },
        {
          "id": 2,
          "text": "6-Phosphogluconate dehydrogenase"
        },
        {
          "id": 3,
          "text": "Erythrocyte transketolase"
        },
        {
          "id": 4,
          "text": "Erythrocyte transaminase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Measurement of <strong>erythrocyte</strong> <strong>transketolase&nbsp;</strong>provides an index of <strong>vitamin B1 </strong>nutritional status.</p>\n<p>Transketolase is an enzyme of the <strong>pentose phosphate pathway&nbsp;</strong>and requires <strong>Mg2+</strong> and <strong>thiamine diphosphate</strong> (vitamin B1) as cofactors. <span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">In thiamine </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">deficiency, the RBC transketolase activity is <strong>reduced</strong>. </span><span>When thiamine diphosphate is added <strong>in-vitro </strong>to erythrocyte lysate, <strong>activation of apo-transketolase</strong> is <strong>suggestive</strong> of B1 <strong>deficiency</strong>.</span></p>\n<div class=\"row mt-3\">\n<div class=\"col-auto\">\n<div class=\"card ng-star-inserted\">\n<div class=\"card-header\"><span>Other enzymes requiring thiamine as a cofactor are:</span></div>\n</div>\n</div>\n</div>\n<ul>\n<li>Branched-chain keto acid dehydrogenase</li>\n<li>Alpha-ketoglutarate dehydrogenase</li>\n<li>Pyruvate dehydrogenase</li>\n<li>Transketolase</li>\n</ul>\n<div class=\"page\" title=\"Page 211\">Options A and B:<strong> Glucose-6-phosphate dehydrogenase </strong>and <strong>6-phosphogluconate dehydrogenase </strong>are involved in the oxidative phase of<strong> the hexose monophosphate (HMP) pathway. </strong>Both enzymes require <strong>NADP<sup>+</sup></strong> and contribute to the formation of <strong>NADPH </strong>and <strong>ribose.</strong></div>\n<div class=\"page\" title=\"Page 211\">&nbsp;</div>\n<div class=\"page\" title=\"Page 211\"><span>Option D: The</span><strong>&nbsp;vitamin B6 nutritional status</strong><span>&nbsp;is by&nbsp;</span><strong>measuring</strong><span>&nbsp;the&nbsp;</span><strong>RBC transaminase activity </strong><span>by adding pyridoxal phosphate in vitro. Direct measurement of the plasma concentrations of the vitamin (pyridoxal phosphate) can also be done.</span></div><hr><h3>Related Pearl: Biochemical Assay for Vitamin Deficiency State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Assay and test</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B1 (Thiamine)</p>\n</td>\n<td>\n<p>RBC Trans-ketolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B2 (Riboflavin)</p>\n</td>\n<td>\n<p>RBC glutathione reductase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 (Pyridoxine)</p>\n</td>\n<td>\n<p>RBC transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B9 (Folic acid)</p>\n</td>\n<td>\n<p>FIGLU excretion/Histidine load test</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B12 (Cobalamine)</p>\n</td>\n<td>\n<p>Serum methyl malonate level</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1871",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is a component of cytochrome oxidase?",
      "choices": [
        {
          "id": 1,
          "text": "Ca2+"
        },
        {
          "id": 2,
          "text": "Cu2+"
        },
        {
          "id": 3,
          "text": "Mn2+"
        },
        {
          "id": 4,
          "text": "Zn2+"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Cu2+</strong> is a component of <strong>cytochrome oxidase.</strong> Cytochrome C oxidase is complex IV of the ETC.</p>\n<p>Components include two heme groups <strong>a</strong> and <strong>a3</strong>, and <strong>copper (Cu).</strong> It is an irreversible complex.</p>\n<p>It receives electrons from complex III (Q-cytochrome C oxidoreductase). Components are <strong>Cyt b</strong>, <strong>Cyt c1. </strong></p>\n<p>The final electron acceptor from complex IV is oxygen and it is reduced to water.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1111",
      "difficulty": "easy"
    },
    {
      "text": "ATP can also be hydrolyzed directly to AMP, with the release of PPi by _________.",
      "choices": [
        {
          "id": 1,
          "text": "Creatine kinase"
        },
        {
          "id": 2,
          "text": "Adenylate kinase"
        },
        {
          "id": 3,
          "text": "Myokinase"
        },
        {
          "id": 4,
          "text": "Acyl-CoA synthetase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>ATP can also be hydrolyzed directly to AMP, with the release of PPi by <strong>Acyl-CoA synthetase enzyme.</strong></p>\n<p>This occurs in the activation of long-chain fatty acids. This reaction is accompanied by the&nbsp;loss of free energy as heat, which ensures that the activation reaction will go to the right. It is further aided by the hydrolytic splitting of PPi, catalyzed by inorganic <strong>pyrophosphatase</strong>, a reaction that itself has a large &Delta;G0&prime; of &minus;19.2 kJ/mol.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5343",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following enzymes is not present in the mitochondrial matrix?",
      "choices": [
        {
          "id": 1,
          "text": "Citric acid cycle enzymes"
        },
        {
          "id": 2,
          "text": "β-oxidation enzymes"
        },
        {
          "id": 3,
          "text": "Pyruvate dehydrogenase"
        },
        {
          "id": 4,
          "text": "ATP synthase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>ATP synthase</strong> is located on the<strong> inner mitochondrial membrane, </strong>not mitochondrial matrix.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/39cfca1ac5e74aea826d31bfbc8c2586x1280x1590.521861777151.JPEG\" alt=\"Explanation Image\"><p>Note: In contrast to the other enzymes of citric acid cycle, <strong>succinate dehydrogenase</strong> is bound to the inner surface of <strong>inner mitochondrial membrane. </strong>Succinate dehydrogenase functions as complex II of electron transport chain.</p><hr><h3>Related Pearl: Electron transport chain: components and its inhibitors</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bcc617cb8a8343ff8c0208d7726a0ba7x1280x1468.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c87ed88288804113994e57192a28d6f8x1280x969.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1102",
      "difficulty": "medium"
    },
    {
      "text": "In oxidative phosphorylation, the ATP production and respiratory chain are linked by ____________",
      "choices": [
        {
          "id": 1,
          "text": "Chemical methods"
        },
        {
          "id": 2,
          "text": "Physical methods"
        },
        {
          "id": 3,
          "text": "Chemiosmotic methods"
        },
        {
          "id": 4,
          "text": "Conformational changes"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The<strong> chemiosmotic theory</strong> states that the two processes (<strong>respiratory chain and synthesis of ATP</strong>) are coupled by a proton gradient across the inner mitochondrial membrane.</p>\n<p>The proton motive force caused by the electrochemical potential difference drives the mechanism of ATP synthesis.</p>\n<p>The <strong>chemiosmotic theory</strong> was proposed by <strong>Peter Mitchell</strong> in 1961.</p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1115",
      "difficulty": "easy"
    },
    {
      "text": "What is fructose 2,6 bisphosphate?",
      "choices": [
        {
          "id": 1,
          "text": "Intermediate metabolite of glycolysis"
        },
        {
          "id": 2,
          "text": "Positive allosteric regulator of PFK1"
        },
        {
          "id": 3,
          "text": "Negative allosteric regulator of PFK2"
        },
        {
          "id": 4,
          "text": "Positive allosteric regulator of PFK2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Fructose 2,6-bisphosphate</strong> is the most potent <strong>positive allosteric activator</strong> of <strong>phosphofructokinase-1</strong> and inhibitor of fructose 1, 6-bisphosphatase. It is not an intermediate of glycolysis.</p>\n<p>Fructose 2, 6-bisphosphate is formed by phosphorylation of fructose-6-phosphate by phosphofructokinase-2. It acts as an intracellular signal, indicating that glucose is abundant and hence causes an <strong>increase </strong>in the<strong> rate of glycolysis</strong> during the<strong> well-fed state</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0450",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an allosteric activator of muscle glycogen phosphorylase?",
      "choices": [
        {
          "id": 1,
          "text": "ATP"
        },
        {
          "id": 2,
          "text": "Insulin"
        },
        {
          "id": 3,
          "text": "Glucose"
        },
        {
          "id": 4,
          "text": "5'AMP"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>5'AMP</strong> serves as the <strong>allosteric activator</strong> of muscle glycogen phosphorylase.</p>\n<p><strong>Glycogen phosphorylase</strong> catalyzes the rate-limiting step in <strong>glycogenolysis</strong>. It is regulated by <strong>allosteric mechanisms</strong> and covalent modification by reversible <strong>phosphorylation</strong> and<strong> dephosphorylation</strong> in response to hormone action.</p>\n<p>In both liver and muscle, the glycogen phosphorylase is:</p>\n<ul>\n<li><strong>Activated</strong> <strong>by phosphorylation</strong> catalyzed by phosphorylase kinase (to yield <strong>phosphorylase a</strong>)</li>\n<li><strong>Inactivated by dephosphorylation</strong> catalyzed by protein phosphatase-1 (to yield<strong> phosphorylase b</strong>)</li>\n</ul>\n<p><strong>Muscle phosphorylase</strong> differs from the liver isoenzyme in having a binding site for <strong>5′ AMP</strong>. It acts as an allosteric activator of the (inactive) dephosphorylated b-form of the enzyme.</p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Allosteric Activator</strong></td>\n<td><strong>Allosteric Inhibitor</strong></td>\n</tr>\n<tr>\n<td><strong>Liver</strong></td>\n<td> </td>\n<td>\n<ul>\n<li>ATP</li>\n<li>Glucose-6-phosphate</li>\n<li>Free glucose</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Muscle </strong></td>\n<td>\n<p>    5' AMP</p>\n</td>\n<td>\n<ul>\n<li>ATP</li>\n<li>Glucose-6-phosphate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/43a2b3d6ff8a4e2fb2595090583f36b1x1280x2560.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1692",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is responsible for the negative charge in fibrinopeptide A?",
      "choices": [
        {
          "id": 1,
          "text": "Glutamate and Valine"
        },
        {
          "id": 2,
          "text": "Histidine and Lysine"
        },
        {
          "id": 3,
          "text": "Aspartate and glutamate"
        },
        {
          "id": 4,
          "text": "Serine and Threonine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Aspartate</strong> and <strong>glutamate</strong> are responsible for the <strong>negative charge</strong> in <strong>fibrinopeptide A</strong> and <strong>B</strong> of <strong>fibrinogen.</strong></p>\n<p><span class=\"fontstyle0\">The negative charges contribute to the solubility of fibrinogen in plasma and importantly also serve to prevent aggregation by causing electrostatic repulsion between fibrinogen molecules.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3651",
      "difficulty": "medium"
    },
    {
      "text": "At physiological pH, buffering action in blood is caused by_______.",
      "choices": [
        {
          "id": 1,
          "text": "Histidine"
        },
        {
          "id": 2,
          "text": "Methionine"
        },
        {
          "id": 3,
          "text": "Arginine"
        },
        {
          "id": 4,
          "text": "Glycine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>At physiological pH<strong>, buffering action in blood </strong>is caused by <strong>histidine. </strong></p>\n<p>The imidazole group of histidine has a<strong> pKa value of 6.5-7.4, </strong>which is<strong> close</strong><strong> to physiological pH.</strong> Hence, histidine has the maximum buffering capacity at physiological pH.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7217",
      "difficulty": "medium"
    },
    {
      "text": "Tetrahydrobiopterin is a coenzyme for all of the following except:",
      "choices": [
        {
          "id": 1,
          "text": "Phenylalanine hydroxylase"
        },
        {
          "id": 2,
          "text": "Tyrosine hydroxylase"
        },
        {
          "id": 3,
          "text": "Tryptophan hydroxylase"
        },
        {
          "id": 4,
          "text": "Homogentisate oxidase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Tetrahydrobiopterin (BH4)</strong> is a coenzyme for the following enzymes:</p>\n<ul>\n<li>Phenylalanine hydroxylase</li>\n<li>Tyrosine hydroxylase</li>\n<li>Tryptophan hydroxylase</li>\n<li>Nitric oxide synthase</li>\n</ul>\n<p>Tetrahydrobiopterin (BH4) resembles folic acid, but it is not a vitamin. It is derived from GTP.</p><hr><h3>Related Pearl: Amino Acid Derivatives</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7b53b3afcc1c47e792f684ad0097deeex1280x1310.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7239",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following enzymes is involved in the process of oxidative deamination?",
      "choices": [
        {
          "id": 1,
          "text": "Glutamate synthetase"
        },
        {
          "id": 2,
          "text": "Glutaminase"
        },
        {
          "id": 3,
          "text": "Glutamate dehydrogenase"
        },
        {
          "id": 4,
          "text": "Glutamate aminotransferase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Glutamate dehydrogenase</strong> is involved in the process of <strong>oxidative deamination.</strong></p>\n<p>In contrast to transamination (transfer amino groups), <strong>oxidative</strong> <strong>deamination</strong> by <strong>glutamate</strong> <strong>dehydrogenase</strong> results in the liberation of the amino group as free ammonia. Glutamate dehydrogenase can use <strong>NADH or NADPH</strong> during oxidative deamination.</p>\n<p>The image below shows oxidative deamination by glutamate dehydrogenase:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5ead5ccdd3404daba2c1ac8d84e4128bx1280x723.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7248",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following amino acids does not undergo transamination?",
      "choices": [
        {
          "id": 1,
          "text": "Methionine"
        },
        {
          "id": 2,
          "text": "Threonine"
        },
        {
          "id": 3,
          "text": "Leucine"
        },
        {
          "id": 4,
          "text": "Glycine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Threonine</strong> does not undergo transamination.</p>\n<p>All amino acids undergo transamination except:</p>\n<ul>\n<li>Proline</li>\n<li>Lysine</li>\n<li>Threonine</li>\n<li>Hydroxyproline</li>\n</ul>\n<p>In transamination, there is a <strong>transfer</strong> of an <strong>amino group</strong> from an<strong> amino acid to a keto acid</strong> to form another pair of amino acids and keto acid, and this reaction is catalyzed by <strong>transaminase</strong>. Transaminases are also known as <strong>aminotransferases</strong> and belong to the class of transferases. They require <strong>pyridoxal pyrophosphate</strong> or vitamin <strong>B6</strong> as their <strong>coenzyme</strong>. It is important in the <strong>biosynthesis</strong> of <strong>non-essential amino acids.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/806bc7912d4d4faf8fd3e264cb2cb565x1010x769.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6831",
      "difficulty": "hard"
    },
    {
      "text": "A patient presents with recurrent kidney stones. Microscopic examination finding of the urine specimen is shown below. Which of the following is not seen in the urine of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Ornithine"
        },
        {
          "id": 2,
          "text": "Lysine"
        },
        {
          "id": 3,
          "text": "Arginine"
        },
        {
          "id": 4,
          "text": "Histidine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The image shows <strong>hexagonal, translucent</strong> and <strong>white crystals</strong> suggestive of <strong>cystinuria. </strong><strong>Histidine</strong> is not seen in the urine of this patient. </p>\n<p><strong> Cystinuria</strong> is an <strong>autosomal-recessive</strong> disease due to a defect in <strong>renal PCT</strong> &amp; intestinal amino acid transporter that is essential for reabsorptive transport of Cystine and the dibasic amino acids Ornithine, Lysine, and Arginine (COLA).</p>\n<p>Diagnosis of cystinuria is by the <strong>cyanide–nitroprusside</strong> test. Initial treatment is with adequate <strong>hydration, alkalization</strong> of the <strong>urine</strong> with <strong>citrate supplementation</strong> or <strong>acetazolamide,</strong> and <strong>dietary modification</strong> to <strong>reduce salt</strong> and <strong>protein intake.</strong> If this fails then patients are usually started on <strong>chelation</strong> therapy with <strong>penicillamine.</strong></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/97ff020d81754547b5b454b82d711b6f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3644",
      "difficulty": "medium"
    },
    {
      "text": "A neonate was brought to the emergency room with lethargy and failure to thrive. A microscopic image of his hair strand is shown below. Which of the given enzymes may be deficient in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Arginosuccinate lyase"
        },
        {
          "id": 2,
          "text": "Arginase"
        },
        {
          "id": 3,
          "text": "Fumarase"
        },
        {
          "id": 4,
          "text": "Tyrosinase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given microscopy image shows<strong> trichorrhexis nodosa </strong>and<strong> longitudinal breaks </strong>and is seen in <strong>argininosuccinic aciduria. </strong>This occurs due to a defect in the enzyme <strong>argininosuccinate lyase.</strong></p>\n<p>Trichorrhexis nodosa is a defect in the hair shaft characterized by thickening or weak points (nodes) that cause the hair to break off easily. It can also be caused by other disorders such as <strong>hypothyroidism, iron deficiency</strong> and <strong>Menkes' kinky</strong> hair syndrome</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b096862d120f4aa783290f55f9b1030c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8413",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following should be avoided by a patient of fish odour syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Biotin"
        },
        {
          "id": 2,
          "text": "Choline"
        },
        {
          "id": 3,
          "text": "Niacin"
        },
        {
          "id": 4,
          "text": "Pantothenic acid"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A fishy odor is seen in <strong>trimethylaminuria.</strong> Consumption of<em> </em>food products with <strong>choline</strong> should be <strong>avoided</strong> in fish odor syndrome.</p>\n<p>Fish odor syndrome (trimethylaminuria) is an <strong>autosomal recessive</strong> disease where TMA(trimethylamine) is not converted to the non-odorous TMAO (TMA-N-oxide) in the liver. This is due to the deficiency of <strong>flavin-containing mono oxygenase 3 (FMO3)</strong>. TMA then builds up in the body and is released in sweat, urine, and breath, giving off a strong <strong>odor</strong> of <strong>rotting</strong> <strong>fish</strong> from the body.</p>\n<p><strong>Choline, lecithin, and TMAO</strong> are precursors of trimethylamine which are found in food products. These food products are eggs, liver, peanuts, meat, poultry, fish, dairy foods, pasta, and rice.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3635",
      "difficulty": "medium"
    },
    {
      "text": "Primary hyperoxaluria is due to the defect in the metabolism of _____.",
      "choices": [
        {
          "id": 1,
          "text": "Threonine"
        },
        {
          "id": 2,
          "text": "Serine"
        },
        {
          "id": 3,
          "text": "Glycine"
        },
        {
          "id": 4,
          "text": "Alanine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Primary hyperoxaluria</strong> is a defect in the metabolism of <strong>glycine.</strong></p>\n<p>The main defect in primary hyperoxaluria type I is the deficiency of the <strong>alanine</strong> <strong>glyoxalate aminotransferase</strong> in liver peroxisomes causing failure to catabolize glyoxylate formed by the deamination of glycine. This leads to a gross overproduction of oxalate, leading to the formation of oxalate stones and subsequent kidney damage.</p><p>The FDA recently approved Lumasiran, RNA interference therapeutic targeting glycolate oxidase as the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder.</p><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8454",
      "difficulty": "medium"
    },
    {
      "text": "All of the following types of interactions cooperate in stabilizing the tertiary structures of globular proteins except _____.",
      "choices": [
        {
          "id": 1,
          "text": "Disulphide bonds"
        },
        {
          "id": 2,
          "text": "Hydrogen bonds"
        },
        {
          "id": 3,
          "text": "Ionic interactions"
        },
        {
          "id": 4,
          "text": "Peptide bonds"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Peptide bonds</strong> are not involved in stabilizing tertiary structure of proteins. It forms the <strong>primary structure</strong> of proteins.</p>\n<p>Interactions stabilizing <strong>tertiary structure</strong> of proteins are as follows:</p>\n<ul>\n<li>Hydrophobic interactions</li>\n<li>Hydrogen bonds</li>\n<li>Ionic interactions</li>\n<li>Disulphide bonds</li>\n</ul>\n<p><strong>Note</strong>:</p>\n<p>Hydrogen bonds and Van der Waal interactions are involved in the formation of α helix (secondary structure).</p><hr><h3>Related Pearl: Structure of proteins</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fd214b3bb95411197397c70b51294d9x1280x2196.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8361",
      "difficulty": "medium"
    },
    {
      "text": "Rossman fold-associated NADH domain is found in _____.",
      "choices": [
        {
          "id": 1,
          "text": "Pyruvate dehydrogenase"
        },
        {
          "id": 2,
          "text": "Lactate dehydrogenase"
        },
        {
          "id": 3,
          "text": "Acetyl CoA dehydrogenase"
        },
        {
          "id": 4,
          "text": "Isocitrate dehydrogenase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Rossmann fold</strong>-associated NADH domain is found in <strong>l</strong><strong>actate dehydrogenase.</strong></p>\n<p>Rossmann fold is an N-terminal <strong>NAD(P)+ -binding domain</strong>. It is seen in:</p>\n<ul>\n<li><strong>Lactate dehydrogenase</strong></li>\n<li>Alcohol dehydrogenase</li>\n<li>Glyceraldehyde-3-phosphate dehydrogenase</li>\n<li>Malate dehydrogenase</li>\n<li>D-glycerate dehydrogenase</li>\n<li>6-phosphogluconate dehydrogenase</li>\n<li>Formate dehydrogenase</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5fe1affdba0148eb9ad195e5bb2563c3x1024x680.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8376",
      "difficulty": "hard"
    },
    {
      "text": "Urea cycle and Krebs cycle are linked at____.",
      "choices": [
        {
          "id": 1,
          "text": "Arginine"
        },
        {
          "id": 2,
          "text": "Ornithine"
        },
        {
          "id": 3,
          "text": "Fumarate"
        },
        {
          "id": 4,
          "text": "Oxaloacetate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The urea cycle and Kreb's cycle are linked at<strong> fumarate.</strong></p>\n<p>In the <strong>urea cycle,</strong> cleavage of <strong>argininosuccinate</strong> to <strong>arginine</strong> releases the aspartate skeleton as <strong>fumarate</strong>. <strong>Fumarate</strong> in <strong>Kreb's</strong> cycle, by the addition of water, converts to <strong>L-malate</strong>.</p><hr><h3>Related Pearl: Urea Cycle and its disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bcc23295f14f9f9b7463912fdb6eeax1280x2235.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Steps involved in TCA cycle</h3><table>\n<tbody>\n<tr>\n<td><strong>Step 1</strong></td>\n</tr>\n<tr>\n<td>\n<p>Acetyl CoA + Oxaloacetate &rarr; Citrate</p>\n<p>&nbsp; &nbsp; &nbsp;(2C &nbsp;+ 4C &nbsp;= &nbsp; 6C)</p>\n<p>Enzyme: Citrate Synthase</p>\n<p><strong>Irreversible</strong>, Exothermic reaction</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 2</strong></td>\n</tr>\n<tr>\n<td>\n<p>Citrate &rarr; Cis &ndash;aconitate&nbsp; &rarr; Isocitrate&nbsp;</p>\n<p>( 6C &nbsp; &nbsp;&rarr; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;6C &rarr; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6C)</p>\n<p>Enzyme:&nbsp;&nbsp; <strong>Aconitase</strong></p>\n<p>Cofactor:&nbsp;&nbsp; Fe<sup>2+</sup></p>\n<p>The Reaction occurs in 2 steps: &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>1<sup>st</sup> step:&nbsp; Dehydration&nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>2<sup>nd</sup> step:&nbsp; Rehydration</p>\n<p>Inhibited by:<strong> Fluoroacetate (Non- Competitive)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 3</strong></td>\n</tr>\n<tr>\n<td>\n<p>Isocitrate &rarr;[Oxalosuccinate]&rarr;&alpha;- Keto glutarate</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; (6C) &rarr; &nbsp; &nbsp; &nbsp; &nbsp; [6C] &nbsp; &nbsp; &nbsp; &nbsp; &rarr; &nbsp; &nbsp; &nbsp; &nbsp; (<strong>5C</strong>)</p>\n<p>Enzyme:&nbsp; Isocitrate Dehydrogenase</p>\n<p>Cofactor:&nbsp;&nbsp; Mn<sup>2+ </sup>or Mg<sup>2+</sup></p>\n<p>Reaction: &nbsp;Oxidative &nbsp;Decarboxylation</p>\n<p><strong>Intermediate:&nbsp;&nbsp; Oxalosuccinate [ Unstable]</strong></p>\n<p>Release:&nbsp;&nbsp;&nbsp; 1 NADH and CO2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 4</strong></td>\n</tr>\n<tr>\n<td>\n<p>&alpha;- Keto glutarate &rarr; Succcinyl Co A&nbsp;</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp;(5C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &rarr; &nbsp; &nbsp; &nbsp; &nbsp; 4C)</p>\n<p>Enzyme: &alpha;- Ketoglutarate Dehydrogenase(Multienzyme complex)</p>\n<p>Reaction:&nbsp; Oxidative Decarboxylation</p>\n<p>Inhibited by: <strong>Arsenite&nbsp; (Non &ndash; Competitive)</strong></p>\n<p>Physiologically <strong>unidirectional</strong> step.</p>\n<p>Release: 1 NADH and CO2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 5</strong></td>\n</tr>\n<tr>\n<td>\n<p>Succinyl- CoA&nbsp; &rarr; Succinate</p>\n<p>&nbsp; &nbsp; &nbsp; ( 4C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&rarr; &nbsp; &nbsp; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme<strong>:&nbsp; Succinate Thiokinase</strong></p>\n<p>Cofactor: Mg<sup>2+</sup></p>\n<p>Release:&nbsp; 1 ATP / GTP</p>\n<p><strong>Substrate level phosphorylation</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 6</strong></td>\n</tr>\n<tr>\n<td>\n<p>Succinate&nbsp; &rarr;&nbsp;&nbsp; Fumarate</p>\n<p>( 4C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&rarr; &nbsp; &nbsp; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme:&nbsp; Succinate Dehydrogenase (Part of 2<sup>nd</sup> complex ETC)</p>\n<p>Cofactor:&nbsp; <strong>FAD and Fe-S protein</strong>&nbsp;</p>\n<p>The only enzyme of TCA cycle attached to the <strong>inner</strong> <strong>mitochondrial membrane.</strong></p>\n<p>Inhibited by:&nbsp;<strong>Malonate</strong>&nbsp;(<strong> competitive)</strong></p>\n<p>Release: FADH<sub>2</sub></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 7</strong></td>\n</tr>\n<tr>\n<td>\n<p>Fumarate&nbsp; &rarr;&nbsp;&nbsp; Malate</p>\n<p>( 4C &nbsp; &nbsp; &nbsp; &nbsp; &rarr; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme:&nbsp; Fumarate Hydratase</p>\n<p>Reaction: Hydration</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 8</strong></td>\n</tr>\n<tr>\n<td>\n<p>Malate&nbsp; &rarr;&nbsp; Oxaloacetate &nbsp;</p>\n<p>( 4C &nbsp; &nbsp; &rarr; &nbsp; &nbsp; &nbsp; &nbsp;4C )</p>\n<p>Enzyme:&nbsp; Malate Dehydrogenase</p>\n<p>Release:&nbsp; 1 NADH</p>\n<p>Oxaloacetate<strong> is</strong> <strong>regenerated.</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/76825a8fa7b34db89430c4b5211dd573x1280x1018.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7270",
      "difficulty": "easy"
    },
    {
      "text": "A 3-day-old child developed lethargy, poor feeding, and hypotonia. An inborn error of metabolism (IEM) panel was sent. Reports reveal hyperammonemia, hyperornithinemia, and homocitrullinuria. What is the most likely defect?",
      "choices": [
        {
          "id": 1,
          "text": "Citrin defect"
        },
        {
          "id": 2,
          "text": "Ornithine transporter defect"
        },
        {
          "id": 3,
          "text": "Carnitine acyl transferase defect"
        },
        {
          "id": 4,
          "text": "Ornithine permease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This child with lethargy, poor feeding, and labs showing <strong>hyperammonemia, hyperornithinemia,</strong> and <strong>homocitrullinuria</strong> most likely has hyperammonemia, hyperornithinemia and homocitrullinuria syndrome (HHH syndrome). This condition is due to an <strong>o</strong><strong>rnithine transporter defect.</strong></p><hr><h3>Related Pearl: Urea Cycle and its disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bcc23295f14f9f9b7463912fdb6eeax1280x2235.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7273",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a saturated fatty acid?",
      "choices": [
        {
          "id": 1,
          "text": "Linoleic acid"
        },
        {
          "id": 2,
          "text": "Caproic acid"
        },
        {
          "id": 3,
          "text": "Myristic acid"
        },
        {
          "id": 4,
          "text": "Palmitic acid"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Linoleic acid</strong> is <strong>not</strong> a saturated fatty acid.</p>\n<p>Linoleic acid is a <strong>polyunsaturated fatty acid </strong>(PUFA) as it has <strong>2 double bonds</strong>. Fatty acids can be classified into:</p>\n<ul>\n<li><strong>Saturated fatty acids</strong>: No double bonds within the chain. Eg: Butyric acid, <strong>caproic acid</strong>, <strong>myristic acid</strong>, <strong>palmitic acid</strong>, stearic acid</li>\n<li><strong>Unsaturated fatty acids</strong>: \n<ul>\n<li><strong>Monounsaturated fatty acids </strong>(MUFA): One double bond within the chain. Eg: Oleic acid</li>\n<li>Polyunsaturated fatty acids<strong> </strong>(PUFA): Two or more double bonds within the chain. Eg: Linoleic acid, Arachidonic acid</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Unsaturated Fatty acids</h3><p>Unsaturated Fatty acids</p>\n<table>\n<tbody>\n<tr>\n<td>Common name</td>\n<td>No. of Carbon atoms: <strong>Number of double bonds</strong>; Position of double bonds</td>\n<td>Family&nbsp;</td>\n<td>Occurrence</td>\n</tr>\n<tr>\n<td>Palmitoleic</td>\n<td>16:<strong>1</strong>;9</td>\n<td>&omega;7</td>\n<td>In nearly all fats</td>\n</tr>\n<tr>\n<td>Oleic</td>\n<td>18:<strong>1</strong>;9</td>\n<td>&omega;9</td>\n<td>The most common fatty acid in<br />natural fats, olive oil</td>\n</tr>\n<tr>\n<td>Elaidic</td>\n<td>18:<strong>1</strong>;9</td>\n<td>&omega;9</td>\n<td>Hydrogenated and ruminant fats</td>\n</tr>\n<tr>\n<td>Linoleic</td>\n<td>18:<strong>2</strong>;9,12</td>\n<td>&omega;6</td>\n<td>Corn, peanut, cottonseed, soybean, and<br />many plant oils</td>\n</tr>\n<tr>\n<td>&gamma;-Linolenic</td>\n<td>18:<strong>3</strong>;6,9,12</td>\n<td>&omega;6</td>\n<td>Some plants, eg, oil of evening primrose,<br />borage oil; minor fatty acid in animals</td>\n</tr>\n<tr>\n<td>&alpha;-Linolenic</td>\n<td>18:<strong>3</strong>;9,12,15</td>\n<td>&omega;3</td>\n<td>Linseed oil</td>\n</tr>\n<tr>\n<td>Arachidonic</td>\n<td>20:<strong>4</strong>;5,8,11,14</td>\n<td>&omega;6</td>\n<td>Animal fats,&nbsp; Phospholipids in animals</td>\n</tr>\n<tr>\n<td>Timnodonic acid</td>\n<td>20:<strong>5</strong>;5,8,11,14,17</td>\n<td>&omega;3</td>\n<td>Fish oils, eg.&nbsp;cod<br />liver, mackerel, menhaden, salmon oils</td>\n</tr>\n<tr>\n<td>Cervonic acid</td>\n<td>22:<strong>6</strong>;4,7,10,13,16,19</td>\n<td>&omega;3</td>\n<td>Fish oils, algal oils, Phospholipids in brain</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9767",
      "difficulty": "easy"
    },
    {
      "text": "What is the respiratory quotient of lipid?",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "0.8"
        },
        {
          "id": 3,
          "text": "0.7"
        },
        {
          "id": 4,
          "text": "0.6"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>respiratory quotient </strong>of lipid is<strong> 0.7</strong></p>\n<p>The respiratory quotient (RQ) is the<strong> molar ratio </strong>of<strong> carbon dioxide produced</strong> to the <strong>oxygen</strong> <strong>consumed </strong>when one mole of a substrate is metabolised. </p><p>Respiratory quotient for various substances</p>\n<table>\n<tbody>\n<tr>\n<td>Substance</td>\n<td>\n<p>RQ (CO<sub>2</sub> Produced/O<sub>2</sub> Consumed)</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate</td>\n<td>1.00<strong> </strong></td>\n</tr>\n<tr>\n<td>Protein</td>\n<td>0.81 </td>\n</tr>\n<tr>\n<td><strong>Fat</strong></td>\n<td><strong>0.71  </strong></td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>0.66</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8086",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following enzymes is required for the only energy-requiring step of fatty acid oxidation?",
      "choices": [
        {
          "id": 1,
          "text": "Thiolase"
        },
        {
          "id": 2,
          "text": "Acyl CoA dehydrogenase"
        },
        {
          "id": 3,
          "text": "Thiokinase"
        },
        {
          "id": 4,
          "text": "Beta-hydroxy acyl Co A dehydrogenase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The only<strong> energy-requiring</strong> step in fatty acid oxidation is catalyzed by the <strong>thiokinase</strong> enzyme.</p>\n<p>In the presence of <strong>ATP</strong> and <strong>coenzyme A</strong>, the enzyme&nbsp;<strong>acyl-CoA synthetase </strong>or&nbsp;<strong>thiokinase</strong> catalyses the conversion of a fatty acid&nbsp;to acyl-CoA, the active form of fatty acid for oxidation.</p><hr><h3>Related Pearl: Enzymes Involved in Fatty acid Transfer Across Mitochondrial membrane</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Enzyme</p>\n</td>\n<td>\n<p>Site of action</p>\n</td>\n<td>\n<p>Action</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acyl-CoA synthetase (Thiokinase)</p>\n</td>\n<td>\n<p>Outer mitochondrial membrane</p>\n</td>\n<td>\n<p>Converts free fatty acid into Acyl CoA</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carnitine palmitoyl transferase-I</p>\n</td>\n<td>\n<p>Outer mitochondrial membrane</p>\n</td>\n<td>\n<p>Transfers long-chain acyl group from CoA to carnitine, forming acylcarnitine.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carnitine-acylcarnitine translocase</p>\n</td>\n<td>\n<p>Inner  mitochondrial membrane</p>\n</td>\n<td>\n<p>Help Acylcarnitine to penetrate the inner membrane</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carnitine palmitoyl transferase-II</p>\n</td>\n<td>\n<p>Inner  mitochondrial membrane</p>\n</td>\n<td>\n<p>Along with carnitine palmitoyl transferase I oxidizes long-chain fatty acids in the mitochondria. </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d27598800f5469bade0f988478cd9f3x1280x1913.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9886",
      "difficulty": "medium"
    },
    {
      "text": "A 3-year-old child is being evaluated for anosmia, deafness, and unstable gait. Further investigation reveals retinitis pigmentosa on fundoscopy and cardiac rhythm abnormalities on ECG. A rare congenital disease affecting lipid metabolism is being suspected. Deficiency of which of the following enzymes is expected to be found in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Phytanoyl CoA α-hydroxylase"
        },
        {
          "id": 2,
          "text": "Acyl CoA synthetase"
        },
        {
          "id": 3,
          "text": "Phytanic acid synthetase"
        },
        {
          "id": 4,
          "text": "None"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical vignette is suggestive of <strong>Refsum&rsquo;s disease</strong>, characterized by <strong>impaired alpha oxidation</strong> due to the <strong>deficiency of phytanoyl CoA &alpha;-hydroxylase</strong> (also known as phytanic acid alpha oxidase).</p>\n<p>Refsum disease is a rare, <strong>autosomal recessive</strong> disorder caused by a deficiency of peroxisomal phytanoyl CoA &alpha;-hydroxylase, an enzyme involved in the alpha oxidation of phytanic acid (branched-chain fatty acid). This results in the <strong>accumulation </strong>of<strong> phytanic acid</strong> in the plasma and <strong>tissues</strong>.</p>\n<p>The manifestation of classic adult Refsum disease includes</p>\n<ul>\n<li aria-level=\"1\">Retinitis pigmentosa</li>\n<li aria-level=\"1\">Peripheral neuropathy</li>\n<li aria-level=\"1\">Ataxia</li>\n<li aria-level=\"1\">Ichthyosis</li>\n<li aria-level=\"1\">Anosmia</li>\n<li aria-level=\"1\">Deafness</li>\n<li aria-level=\"1\">Occasionally cardiac arrhythmias</li>\n</ul>\n<p>Treatment: Restriction of dietary phytanic acid (found in dairy products and green leafy vegetables).</p><hr><h3>Related Pearl: Types, Location and Properties of Fatty acid oxidation</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Types of Oxidation</strong></p>\n</td>\n<td>\n<p><strong>Location</strong></p>\n</td>\n<td>\n<p><strong>Properties</strong></p>\n</td>\n<td>\n<p><strong>Associated Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Beta oxidation</p>\n</td>\n<td>\n<p>Mitochondria</p>\n</td>\n<td>\n<p>A catabolic process by which two-carbons are cleaved from the fatty acid molecule and released as acetyl CoA starting from the carboxyl end.</p>\n<p>The chain is broken between the &alpha;(2) and&nbsp;&beta;(3) carbon.</p>\n<p>1 round of beta-oxidation yield 1FADH2, 1NADH, and 1 Acetyl CoA.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alpha oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>The presence of the 3-methyl group of phytanic acid prevents degradation by beta-oxidation.</p>\n<p>The chain is broken between the terminal carboxyl group and &alpha;(2) carbon removing that carbon as CO2. The remaining chain is activated with CoA and then undergoes&nbsp;&beta;-Oxidation.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Classic Refsum's Disease</p>\n<p>Defective enzyme- Phytanoyl Coa hydroxylase.</p>\n<p>Clinical features include:</p>\n<p>Ichthyosis, Retinitis pigmentosa, Decreased vision, Peripheral neuropathy, Ataxia</p>\n<p class=\"p2\">&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Omega oxidation</p>\n</td>\n<td>\n<p>Endoplasmic Reticulum</p>\n</td>\n<td>\n<p>An alternative pathway to beta-oxidation occurs in microsomes.</p>\n<p>Involves the&nbsp;oxidation&nbsp;of the &omega; carbon (terminal methyl group) resulting in dicarboxylic acid.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Peroxisomal Beta oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>Very-long-chain fatty acids undergo preliminary &beta;-oxidation in peroxisomes up to&nbsp;octanoyl CoA.&nbsp;The shortened fatty acids undergo further &beta;-oxidation in the mitochondria.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Zellweger (cerebrohepatorenal) syndrome</p>\n<p>A rare inherited absence of peroxisomes in all tissues.</p>\n<p class=\"p2\">They accumulate C<span class=\"s1\">26</span>&mdash;C<span class=\"s1\">38 </span>polyenoic acids in brain tissue and also exhibit a generalized loss of peroxisomal functions. The disease causes severe neurologic symptoms, and most patients die in the first year of life.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9898",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an allosteric activator of acetyl CoA carboxylase?",
      "choices": [
        {
          "id": 1,
          "text": "Citrate"
        },
        {
          "id": 2,
          "text": "Acetate"
        },
        {
          "id": 3,
          "text": "Malate"
        },
        {
          "id": 4,
          "text": "Palmitate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Citrate</strong> is an <strong>allosteric</strong> <strong>activator </strong>of <strong>acetyl-CoA carboxylase</strong>.</p>\n<p>Acetyl-CoA carboxylase is the rate-limiting enzyme in de novo fatty acid synthesis. Citrate promotes the conversion of acetyl CoA carboxylase from an<strong> inactive dimer</strong> to an <strong>active polymeric form</strong>. Its concentration increases in the<strong> well-fed state</strong>. <strong>Insulin</strong> also activates the enzyme by dephosphorylating it.<strong> </strong></p>\n<p><strong>Glucagon</strong> and <strong>epinephrine</strong> promote <strong>inactivation</strong> of acetyl-CoA-carboxylase by <strong>phosphorylation</strong> of the enzyme. <strong>Long-chain acyl-CoA molecules</strong> such as palmitoyl CoA also promotes inactivation of the enzyme.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/93d912fcaaa4402498c5e896fe0bcef5x600x392.JPEG\" alt=\"Explanation Image\"><table>\n<tbody>\n<tr>\n<td colspan=\"3\">Examples of allosteric modifiers</td>\n</tr>\n<tr>\n<td>Enzyme</td>\n<td>Allosteric inhibitor</td>\n<td>Allosteric activator</td>\n</tr>\n<tr>\n<td>1. ALA synthase</td>\n<td>Heme</td>\n<td>-</td>\n</tr>\n<tr>\n<td>2. Aspartate transcarbamoylase</td>\n<td>CTP</td>\n<td>ATP</td>\n</tr>\n<tr>\n<td>3. HMG CoA reductase</td>\n<td>Cholesterol</td>\n<td>-</td>\n</tr>\n<tr>\n<td>4.Phosphofructokinase</td>\n<td>Citrate, ATP</td>\n<td>AMP, F2,6P</td>\n</tr>\n<tr>\n<td>5. Acetyl CoA carboxylase</td>\n<td>Acyl CoA</td>\n<td>Citrate</td>\n</tr>\n<tr>\n<td>6. Citrate synthase</td>\n<td>ATP</td>\n<td>-</td>\n</tr>\n<tr>\n<td>7. Carbamoyl phosphate synthase-I</td>\n<td>-</td>\n<td>NAG</td>\n</tr>\n<tr>\n<td>8. Carbamoyl phosphate synthase-II</td>\n<td>-</td>\n<td>ATP</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9934",
      "difficulty": "easy"
    },
    {
      "text": "A 7-year-old girl presents with sudden onset of severe breathlessness with wheezing. Her peak expiratory flow rate is reduced significantly. Which of the following enzymes is important for the pathogenesis of the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "7-Lipoxygenase"
        },
        {
          "id": 2,
          "text": "12-Lipoxygenase"
        },
        {
          "id": 3,
          "text": "15-Lipoxygenase"
        },
        {
          "id": 4,
          "text": "5-Lipoxygenase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p1\">Sudden onset of severe breathlessness and wheezing with a reduced peak expiratory flow rate is suggestive of <strong>acute exacerbation </strong>of <strong>asthma.</strong> <strong>5-lipoxygenase</strong> enzyme is important for the pathogenesis of this condition. </p>\n<p class=\"p1\">Acute exacerbation of asthma is characterized by <strong>bronchoconstriction</strong> due to chemicals mediators like <strong>leukotrienes</strong> (LTB<sub>4</sub>, LTC<sub>4</sub>, LTD<sub>4</sub> etc.). Leukotrienes are produced from the breakdown of <strong>arachidonic acid</strong> by 5-lipoxygenase<strong> </strong>via the<strong> lipoxygenase pathway. </strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5c4613d9ee8b4913a9a571ac5929e453x1280x2588.JPEG\" alt=\"Explanation Image\"><p class=\"p1\">Leukotrienes<span class=\"Apple-converted-space\"> </span>are <strong>eicosanoic acid </strong>derivatives formed in leukocytes, mast cells, platelets, and macrophages. They are<strong> potent constrictors</strong> of the<strong> bronchial airway. </strong>Leukotrienes<span class=\"s1\"> </span>also cause increased <strong>vascular permeability</strong> and activation and<strong> attraction </strong>of <strong>leukocytes. </strong>Thus, they are involved in many inflammatory or <strong>immediate hypersensitivity reactions,</strong> such as asthma. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0163",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following phospholipids is a constituent of the human lung surfactant?",
      "choices": [
        {
          "id": 1,
          "text": "Dipalmitoyl lecithin"
        },
        {
          "id": 2,
          "text": "Cardiolipin"
        },
        {
          "id": 3,
          "text": "Phosphatidylinositol"
        },
        {
          "id": 4,
          "text": "Phosphatidylserine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Dipalmitoyl lecithin/Dipalmitoylphosphatidylcholine (DPPC) </strong>is a major component of <strong>lung surfactant.</strong></p>\n<p>In DPPC, positions 1 &amp; 2 on the glycerol are occupied by <strong>palmitate</strong>. </p>\n<p>Surfactant is secreted by the <strong>type 2 pneumocytes</strong> in the alveoli. It <strong>reduces surface tension</strong> at the air-liquid interface of the alveolus.</p>\n<p>Clinical correlate :</p>\n<ul>\n<li><strong>Respiratory distress syndrome (RDS)</strong> in preterm neonates is due to insufficient surfactant production.</li>\n<li><strong>Lung maturity</strong> of the fetus can be assessed by determining the ratio of lecithin to sphingomyelin <strong>(L:S ratio)</strong> in the <strong>amniotic fluid</strong>. A ratio of <strong>&gt;2</strong> <strong>indicates maturity</strong>.</li>\n</ul><hr><h3>Related Pearl: Pulmonary Surfactant Composition</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Constituents</strong></p>\n</td>\n<td>\n<p><strong>Percentage</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phospholipids, mainly dipalmitoylphosphatidylcholine (DPPC)</p>\n</td>\n<td>\n<p>70% to 80%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Proteins</p>\n</td>\n<td>\n<p>10%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neutral lipids</p>\n</td>\n<td>\n<p>10%</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0040",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following phospholipids is found only in the mitochondria and helps in the mitochondrial function?",
      "choices": [
        {
          "id": 1,
          "text": "Cephalin"
        },
        {
          "id": 2,
          "text": "Cardiolipin"
        },
        {
          "id": 3,
          "text": "Lecithin"
        },
        {
          "id": 4,
          "text": "Plasmalogen"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Cardiolipin</strong> is the phospholipid found <strong>only</strong> in the <strong>mitochondria. </strong></p>\n<p>Cardiolipin is an important component of the <strong>inner mitochondrial membrane. </strong>It is essential for the <strong>optimal function</strong> of numerous mitochondrial <strong>enzymes</strong> involved in mitochondrial <strong>energy metabolism</strong> and for the <strong>maintenance </strong>of the<strong> </strong>mitochondrial membrane <strong>structure. </strong></p>\n<p><strong>Decreased cardiolipin</strong> or alteration in its metabolism results in<strong> </strong>mitochondrial dysfunction. This is<strong> </strong>seen in<strong> Barth syndrome </strong>(cardioskeletal myopathy) which is <span class=\"ILfuVd\"><span class=\"hgKElc\">characterized by an enlarged and weakened heart (<strong>dilated cardiomyopathy</strong>), weakness in muscles used for movement (<strong>skeletal myopathy</strong>), recurrent infections due to small numbers of white blood cells (<strong>neutropenia</strong>), and <strong>short stature</strong>.</span></span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0042",
      "difficulty": "medium"
    },
    {
      "text": "A 6-month-old infant with progressive failure to thrive and milestone regression is being evaluated for an inborn error of metabolism. On examination, hypotonia, apathy, deafness, hepatosplenomegaly, and generalized lymphadenopathy are present. Fundus examination is shown below. A liver biopsy shows foamy hepatocytes loaded with sphingomyelin. Electron microscopy reveals zebra bodies. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Niemann-Pick disease type A"
        },
        {
          "id": 2,
          "text": "Tay-Sach disease"
        },
        {
          "id": 3,
          "text": "Niemann-Pick disease type B"
        },
        {
          "id": 4,
          "text": "Sandhoff's disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Progressive failure to thrive, milestone regression, hypotonia, apathy, deafness, hepatosplenomegaly, and generalized lymphadenopathy with the <strong>cherry-red spot</strong> on fundus examination suggests a diagnosis of<strong> Niemann-Pick disease type A. </strong></p>\n<p> Niemann-Pick disease is a lysosomal storage disorder due to an inherited <strong>deficiency </strong>of <strong>sphingomyelinase. </strong>This results in the accumulation of<strong> sphingomyelin</strong> in the monocyte-macrophage system. <strong>Type A </strong>disease is a severe<strong> infantile</strong> form. Infants present with <strong>extensive neurologic involvement </strong>(hypotonia, milestone regression, apathy),<strong> marked visceral accumulations </strong>of <strong>sphingomyelin</strong> (hepatosplenomegaly, foamy hepatocytes, <strong>zebra bodies</strong> on EM),<strong> progressive wasting</strong> and<strong> early death</strong> within the first 3 years of life.</p>\n<p>In contrast, patients with<strong> Niemann-Pick disease type B</strong> have organomegaly but generally <strong>no CNS involvement.</strong></p><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Niemann-Pick Disease Types and Symptoms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Types</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type A</p>\n</td>\n<td>\n<p>First few months of life</p>\n<p>Abdominal (belly area) swelling within 3 - 6 months</p>\n<p>Cherry red spot in the eye</p>\n<p>Feeding difficulties</p>\n<p>Loss of early motor skills (gets worse over time)</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type B</p>\n</td>\n<td>\n<p>Late childhood or the teenage years.&nbsp;</p>\n<p>Abdominal swelling may occur in young children.&nbsp;</p>\n<p>There is almost no brain and nervous system involvement, such as loss of motor skills.&nbsp;</p>\n<p>Some patients may have repeated respiratory infections</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type C</p>\n</td>\n<td>\n<p>Between early infancy to adulthood Difficulty moving limbs (dystonia)</p>\n<p>Enlarged spleen</p>\n<p>Enlarged liver</p>\n<p>Jaundice at (or&nbsp;shortly after) birth</p>\n<p>Dementia</p>\n<p>Seizures</p>\n<p>Slurred, irregular speech</p>\n<p>Cataplexy</p>\n<p>Tremors</p>\n<p>Vertical supranuclear gaze palsy</p>\n<p>Ataxia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type D</p>\n</td>\n<td>\n<p>Same As C</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0f716f89fa9a4370bbdb7b6295a1acee.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0052",
      "difficulty": "easy"
    },
    {
      "text": "An 8-year-old boy presents with burning pain and numbness in his hands, heat intolerance and decreased visual acuity. Further evaluation reveals skin angiokeratomas and a decreased renal function. Which of the following is the mode of inheritance of the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Autosomal recessive"
        },
        {
          "id": 2,
          "text": "X-linked recessive"
        },
        {
          "id": 3,
          "text": "Autosomal dominant"
        },
        {
          "id": 4,
          "text": "X-linked dominant"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Burning pain and numbness in hands, heat intolerance, decreased visual acuity with skin angiokeratomas and a decreased renal function is suggestive of <strong>Fabry’s disease</strong> which is inherited as an <strong>X-linked recessive disorder.</strong></p>\n<p><strong>Fabry’s disease </strong>is a lipid storage disorder due to a deficiency of <strong>α-galactosidase A, </strong>resulting in the accumulation of <strong>g</strong><strong>lobotriaosyl-ceramide</strong> in tissues. Young boys present with<strong> Fabry crises </strong>(burning pain in the hands, feet and proximal extremities), <strong>angiokeratomas </strong>(reddish blue telangiectatic skin lesions between the umbilicus and knees), corneal and lenticular opacities, <strong>renal failure </strong>and cardiomyopathy.</p>\n<p>Note: <strong>All sphingolipidoses</strong> are inherited in an <strong>autosomal recessive</strong> manner,<strong> except </strong>Fabry’s disease.</p><p>Most of the common metabolic disorders are <strong>autosomal recessive</strong> disorders, except:</p>\n<p>1. Autosomal dominant disorders:</p>\n<ul>\n<li>Familial hypercholesterolemia</li>\n</ul>\n<p>2. X-linked recessive disorders:</p>\n<ul>\n<li>Hunter syndrome</li>\n<li>Fabry disease</li>\n<li>Lesch-Nyhan syndrome</li>\n<li>OTC deficiency</li>\n</ul><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0053",
      "difficulty": "medium"
    },
    {
      "text": "Accumulation of which of the following substances is responsible for Farber’s disease?",
      "choices": [
        {
          "id": 1,
          "text": "Lecithin"
        },
        {
          "id": 2,
          "text": "Ceramide"
        },
        {
          "id": 3,
          "text": "Sphingomyelin"
        },
        {
          "id": 4,
          "text": "Sulfatides"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Accumulation </strong>of <strong>c</strong><strong>eramide</strong> is seen in <strong>Farber’s disease. </strong></p>\n<p><strong>Farber's disease </strong>occurs due to<strong> deficiency </strong>of <strong>ceramidase</strong>, which catalyses the breakdown of ceramide to fatty acid and sphingosine. Affected children present with <strong>p</strong><strong>ainful joint</strong> swelling and nodules, <strong>progressive joint deformity</strong>, <strong>h</strong><strong>oarse cry </strong>and <strong>b</strong><strong>reathing difficulty, </strong>mental retardation and <strong>f</strong><strong>ailure </strong>to<strong> thrive. </strong></p><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0056",
      "difficulty": "easy"
    },
    {
      "text": "Which is the first steroid to be produced in cholesterol synthesis?",
      "choices": [
        {
          "id": 1,
          "text": "Cholecystokinin"
        },
        {
          "id": 2,
          "text": "Epinephrine"
        },
        {
          "id": 3,
          "text": "Lanosterol"
        },
        {
          "id": 4,
          "text": "Secretin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Lanosterol</strong> is the <strong>first steroid</strong> to be synthesized <strong>in cholesterol synthesis</strong>.</p>\n<ul>\n<li>Cyclization of squalene gives rise to the parent steroid, lanosterol.</li>\n<li>The formation of cholesterol from lanosterol involves changes in the steroid nucleus and the side chain.</li>\n</ul><hr><h3>Related Pearl: Cholesterol synthesis</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/df36006c4ce64fe88295b170ef95d661x600x910.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9968",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following has the highest electrophoretic mobility and least lipid content?",
      "choices": [
        {
          "id": 1,
          "text": "Chylomicrons"
        },
        {
          "id": 2,
          "text": "HDL"
        },
        {
          "id": 3,
          "text": "LDL"
        },
        {
          "id": 4,
          "text": "VLDL"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>HDL</strong> has the <strong>highest</strong> <strong>electrophoretic</strong> <strong>mobility</strong> and the <strong>least lipid</strong> content. HDL particles are the densest.</p>\n<p>On electrophoresis, HDL moves farthest on the electrophoretic plate towards the anode. On the other hand, the <strong>chylomicron does not move</strong> towards the charged end in electrophoresis, thus having the lowest mobility. As a general rule,<strong> lipoproteins</strong> with <strong>higher protein</strong> content will <strong>move faster</strong> towards the <strong>anode</strong> and those with fewer proteins have minimal mobility.</p>\n<p>The density of various lipoproteins and their electrophoretic mobility are shown in the images below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2076687af52640e28cd52733b51efb77x1280x1190.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9987",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is an activator of the key enzyme required in reverse cholesterol transport?",
      "choices": [
        {
          "id": 1,
          "text": "Apo B-100"
        },
        {
          "id": 2,
          "text": "Apo B-48"
        },
        {
          "id": 3,
          "text": "Apo A-IV"
        },
        {
          "id": 4,
          "text": "Apo A-I"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Apo A-I</strong> is the <strong>activator</strong> of <strong>Lecithin: cholesterol acyltransferase (LCAT)</strong>, the enzyme present in <strong>HDL</strong> facilitating <strong>reverse cholesterol transport.</strong></p>\n<p>Lecithin-cholesterol acyltransferase (LCAT) is activated by apo A-I which then converts <strong>free cholesterol(amphipathic)</strong> in HDL to <strong>cholesterol ester(hydrophobic)</strong>. As a result the initial discoidal shape now becomes spherical.</p>\n<p>This facilitates <strong>reverse cholesterol transport.</strong></p>\n<p>Clinical correlation: <strong>Familial LCAT deficiency</strong> will lead to failure of reverse cholesterol transport resulting in <strong>cholesterol deposition</strong> in specific <strong>peripheral tissues </strong>- the<strong> cornea, kidneys, </strong>and <strong>erythrocytes</strong>. Major complications include <strong>premature atherosclerosis, </strong>renal failure, anemia and corneal opacities<strong>.</strong> HDL cholesterol level is decreased.</p><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9983",
      "difficulty": "medium"
    },
    {
      "text": "What is the first step in synthesis of eicosanoids?",
      "choices": [
        {
          "id": 1,
          "text": "Activation of PGH2 synthetase"
        },
        {
          "id": 2,
          "text": "Activation of lipooxygenase"
        },
        {
          "id": 3,
          "text": "Activation of hydrolase"
        },
        {
          "id": 4,
          "text": "Activation of cyclooxygenase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>first step </strong>in the<strong> synthesis</strong> of <strong>eicosanoids</strong> involves the <strong>activation </strong>of <strong>hydrolase</strong>.</p>\n<p>Eicosanoid synthesis is governed by the rate of release of <strong>arachidonic acid</strong> from membrane lipids in response to appropriate stimuli (Eg: Increased calcium). These stimuli activate <strong>hydrolases</strong>, including <strong>phospholipase A<sub>2</sub></strong>, which releases arachidonic acid from membrane phospholipids. The released arachidonic acid is then converted into:</p>\n<ul>\n<li>Prostaglandins and thromboxanes by the <strong>cyclooxygenase</strong> (COX) pathway. <strong>PGH2 synthase</strong> is the first enzyme of this pathway. </li>\n<li>Leukotrienes and lipoxins by the <strong>lipooxygenase </strong>(LOX) pathway</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/364d110205114669a30e8479d7e4625ax1024x700.jpeg\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0129",
      "difficulty": "hard"
    },
    {
      "text": "What is the by-product of the ​reaction catalyzed by cytosolic hydroxymethylbilane synthase in heme synthesis?",
      "choices": [
        {
          "id": 1,
          "text": "H2O"
        },
        {
          "id": 2,
          "text": "NH3"
        },
        {
          "id": 3,
          "text": "CO2"
        },
        {
          "id": 4,
          "text": "CoA.SH"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The by-product of the reaction catalyzed by cytosolic <strong>hydroxymethylbilane</strong> (HMB)<strong> synthase</strong> in heme synthesis is <strong>ammonia </strong>(NH<sub>3</sub>). </p>\n<p>HMB synthase is also known as<strong> porphobilinogen deaminase </strong>or <strong>uroporphyrinogen 1 synthase.</strong> It catalyses the <strong>condensation</strong> of 4 molecules of porphobilinogen to release hydroxymethylbilane and <strong>4 molecules </strong>of NH<sub>3</sub>. </p>\n<p>4 Porphobilinogen + H<sub>2</sub>O -------&gt; Hydroxymethylbilane + 4 NH<sub>3</sub></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/23fbcc01b1044a7288535162a28e7fb2x1280x1732.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0704",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the rate-limiting enzyme in the hepatic biosynthesis of heme?<div class='question-desc-html'><p>(ALA - α- aminolevulinate)</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "ALA Synthase"
        },
        {
          "id": 2,
          "text": "Uroporphyrinogen III synthase"
        },
        {
          "id": 3,
          "text": "ALA dehydratase"
        },
        {
          "id": 4,
          "text": "Ferrochelatase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>rate-limiting enzyme</strong> in the hepatic biosynthesis of heme is mitochondrial <strong>ALA synthase. </strong></p>\n<p>ALA synthase (ALAS) is a<strong> mitochondrial </strong>enzyme catalysing the conversion of succinyl CoA and glycine to ALA. There are two isozymes of ALA synthase. <strong>ALAS-1</strong> is expressed throughout the body. It is <strong>induced</strong> by drugs whose metabolism requires<strong> cytochromes </strong>(hemoprotein). <strong>Heme, </strong>probably acting through an <strong>aporepressor</strong> molecule, acts as a<strong> negative regulator </strong>of the synthesis of<strong> </strong>ALAS-1<strong> </strong>i.e. ALAS-1 synthesis decreases in the presence of heme. </p>\n<p><strong>ALAS-2</strong> is expressed in the <strong>erythrocyte precursor cells. </strong>It is neither induced by drugs<strong> </strong>nor is its feedback regulated by heme.<strong><br /></strong></p>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0a039fd29e264b72a94ddbcd4cf40f94x1280x1732.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0706",
      "difficulty": "easy"
    },
    {
      "text": "Which  of the following is not a hepatic porphyria?",
      "choices": [
        {
          "id": 1,
          "text": "Variegate porphyria"
        },
        {
          "id": 2,
          "text": "Acute intermittent porphyria"
        },
        {
          "id": 3,
          "text": "Porphyria cutanea tarda"
        },
        {
          "id": 4,
          "text": "Erythropoietic protoporphyria"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Erythropoietic protoporphyria</strong> is <strong>not</strong> a type of <strong>hepatic porphyria. </strong></p>\n<p>Porphyrias are classified into<strong> erythropoietic</strong> and <strong>hepatic</strong> porphyrias, based on the location of accumulation of heme pathway intermediates:</p>\n<ol>\n<li><strong>Erythropoietic porphyrias:</strong>\n<ol>\n<li>The overproduction of heme pathway intermediates occurs primarily in bone marrow erythroid cells.</li>\n<li>They are characterized by <strong>cutaneous symptoms</strong> and appear in early childhood.</li>\n<li>Examples: Congenital erythropoietic porphyria, <strong>erythropoietic protoporphyria</strong>, X-linked protoporphyria</li>\n</ol>\n</li>\n<li><strong>Hepatic porphyrias: </strong>\n<ol>\n<li>The overproduction of heme pathway intermediates occurs primarily in<strong> </strong>the liver.</li>\n<li><strong>Acute hepatic porphyrias</strong><span> are characterised by <strong>neurologic symptoms</strong> and present acutely. </span>Examples: Acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, ALA dehydratase deficient porphyria</li>\n<li><strong>Chronic hepatic porphyrias</strong><span> </span><span>present in adulthood with <strong>photosensitivity</strong>. Example: Porphyria cutanea tarda</span></li>\n</ol>\n</li>\n</ol><hr><h3>Related Pearl: Types of porphyria</h3><p>Clinically porphyrias can be classified into:</p>\n<ul>\n<li>Hepatic porphyria: The overproduction of heme pathway intermediates occurs primarily in the liver.</li>\n<li>Erythropoietic porphyria: The overproduction of heme pathway intermediates occurs primarily in bone marrow erythroid cells.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2370f6a3e9e64db5b0d342d7fc4a410fx1280x1964.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Porphyria type</strong></span></div>\n</td>\n<td>\n<div><span><strong>Deficient </strong> <strong>enzyme</strong></span></div>\n</td>\n<td>\n<div><span><strong>Lab findings</strong></span></div>\n</td>\n<td> </td>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>X-linked dominant protoporphyria</span></div>\n<div><span>(XLDPP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate synthase 2</span></div>\n<div><span>(ALAS - 2)</span></div>\n</td>\n<td><span>Decreased RBC count and hemoglobin</span></td>\n<td>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Aminolevulinate dehydratase deficiency porphyria</span></div>\n<div><span>(ALADP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate dehydratase</span></div>\n<div><span>(ALAD)</span></div>\n</td>\n<td><span>Increased urinary ALA and coproporphyrin III </span></td>\n<td><span>Neurovisceral symptoms</span></td>\n<td>\n<div><span>Abdominal pain, neuropathy</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Acute intermittent porphyria</span></div>\n<div><span>(AIP)</span></div>\n</td>\n<td>\n<div><span>Hydroxymethylbilane synthase</span></div>\n<div><span>(Uroporphyrin I synthase)</span></div>\n</td>\n<td><span>Increased urinary ALA and PBG </span></td>\n<td><span>Neurovisceral symptoms </span></td>\n<td>\n<div><span>Periodic abdominal pain, peripheral neuropathy, psychiatric symptoms, tachycardia</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Congenital Erythropoietic porphyria</span></div>\n<div><span>(CEP)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen III synthase</span></div>\n<div><span>(UROS)</span></div>\n</td>\n<td><span>Increased urinary, fecal and red cell uroporphyrin I</span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Severe photosensitivity with erythema, swelling and blistering, hemolytic anemia, splenomegaly</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Porphyria cutanea tarda (PCT)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen decarboxylase</span></div>\n<div><span>(UROD)</span></div>\n</td>\n<td><span>Increased uroporphyrin I</span></td>\n<td><span> </span>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity with vesicles and bullae</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Hereditary coproporphyria</span></div>\n<div><span>(HCP)</span></div>\n</td>\n<td>\n<div><span>Coproporphyrinogen oxidase</span></div>\n<div><span>(CPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal coproporphyrin III</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, abdominal colic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Variegate porphyria</span></div>\n<div><span>(VP)</span></div>\n</td>\n<td>\n<div><span>Protoporphyrinogen oxidase</span></div>\n<div><span>(PPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal protoporphyrin IX</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, developmental delay</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Erythropoietic protoporphyria</span></div>\n<div><span>(EPP)</span></div>\n</td>\n<td>\n<div><span>Ferrochelatase</span></div>\n<div><span>(FECH)</span></div>\n</td>\n<td><span>Increased fecal and red cell protoporphyrin IX </span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Non-blistering Photosensitivity with skin lesions</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div><span> </span></div>\n<div><span>Most porphyrias are <strong>autosomal dominant</strong> <strong>except:</strong></span></div>\n<div>\n<ul>\n<li><span>ALAD enzyme deficiency porphyria</span></li>\n<li><span>Congenital erythropoietic porphyria</span></li>\n<li><span>Erythropoietic protoporphyria</span></li>\n<li><span>X-linked protoporphyria</span></li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0722",
      "difficulty": "medium"
    },
    {
      "text": "All of the following is true about isoenzymes except ________.",
      "choices": [
        {
          "id": 1,
          "text": "They catalyze the same reaction."
        },
        {
          "id": 2,
          "text": "They have the same number of charged amino acids."
        },
        {
          "id": 3,
          "text": "They can be separated by electrophoresis."
        },
        {
          "id": 4,
          "text": "They differ in tissue localization."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Isoenzymes <strong>do not have</strong> the same number of charged amino acids.</p>\n<p>Isoenzymes are physically distinct forms of the same enzyme. They <strong>catalyze</strong> the <strong>same reaction</strong> but differ in the following:</p>\n<ul>\n<li><strong>Amino acid sequence</strong> and the number of <strong>charged amino acids</strong></li>\n<li><strong>Subunit</strong> composition: CK-1 contains BB while CK-2 contains MB subunits</li>\n<li><strong>Electrophoretic</strong> mobility: CK-1 moves faster than CK-3</li>\n<li><strong>Tissue localization:</strong> CK-1 is present in the brain, CK-2 in the heart</li>\n<li><strong>Substrate affinity:</strong> Glucokinase has low affinity but hexokinase has high affinity.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0806",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is false about non-competitive inhibition?",
      "choices": [
        {
          "id": 1,
          "text": "Vmax decreases"
        },
        {
          "id": 2,
          "text": "Km decreases"
        },
        {
          "id": 3,
          "text": "The inhibitor binds at a site different from the active site"
        },
        {
          "id": 4,
          "text": "The inhibitor does not affect the binding of the substrate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>K<sub>m</sub> remains<strong> constant</strong> in <strong>noncompetitive inhibition.</strong></p>\n<p>Non-competitive inhibition of enzymes occurs by the binding of inhibitors to enzymes in locations <strong>different</strong> from the <strong>active site</strong>. The inhibition is <strong>not overcome</strong> by<strong> increasing</strong> the <strong>concentratio</strong>n of the substrate. Thus, noncompetitive inhibitors <strong>decrease</strong> the <strong>V<sub>max</sub></strong> of the reaction.</p>\n<p>Non-competitive inhibtiors do not resemble the<strong> </strong>substrate. Thus, they d<strong>o not interfere</strong> with the <strong>binding</strong> of the substrate to the enzyme. Thus, K<sub>m</sub> of the enzyme does not change.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/05254662368745adb145b8b5c51db9e5x1280x1431.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a3b234ddebb64cb6a71325522d1b331ex1280x2317.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Difference between Competitive & Non-Competitive inhibitors</h3><p>Reversible inhibitors are of two types:</p>\n<ul>\n<li>Competitive inhibitors</li>\n<li>Non-Competitive inhibitors</li>\n</ul>\n<p>Difference between Competitive &amp; Non-Competitive inhibitors</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Competitive inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Non-Competitive inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Succinate dehydrogenase is inhibited by Malonate</p>\n</td>\n<td>\n<p>Pyruvate kinase is inhibited by alanine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Substrate &amp; inhibitor are chemically similar &amp; have same shape</p>\n</td>\n<td>\n<p>Substrate &amp; inhibitor are chemically not similar &amp; have different shape</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor binds to active site</p>\n</td>\n<td>\n<p>Inhibitor binds away from active site, i.e., at allosteric site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor does not change the shape of the active site</p>\n</td>\n<td>\n<p>Inhibitor changes the shape of the active site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Increase in substrate concentration reduces the inhibition</p>\n</td>\n<td>\n<p>Increase in substrate concentration does not affect the inhibition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vmax remains constant</p>\n</td>\n<td>\n<p>Vmax decreases</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Km Increases</p>\n</td>\n<td>\n<p>Km remains constant</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1190",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is true regarding an allosteric modifier?",
      "choices": [
        {
          "id": 1,
          "text": "Desaturates the enzyme"
        },
        {
          "id": 2,
          "text": "Causes the enzyme to work faster only."
        },
        {
          "id": 3,
          "text": "Binds to the catalytic site"
        },
        {
          "id": 4,
          "text": "Participates in feedback regulation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>An <strong>allosteric modifier</strong> of an enzyme usually participates in <strong>feedback regulation</strong>.</p>\n<p>Allosteric regulations are a natural example of control loops, such as <strong>feedback </strong>from<strong> downstream products</strong> or <strong>feedforward </strong>from <strong>upstream substrates</strong>. Allosteric regulation is also particularly important in the cell's ability to adjust enzyme activity. </p>\n<p>An allosteric <strong>modifier</strong> or <strong>effector</strong> binds to the <strong>allosteric site</strong> to induce a<strong> conformational change</strong> in the <strong>catalytic</strong> or <strong>active</strong> <strong>site</strong><strong>. </strong>Those modifiers or effectors that enhance the protein's activity are referred to as <strong>allosteric activators</strong>, whereas those that decrease the protein's activity are called <strong>allosteric inhibitors</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\"> Some examples of allosteric modifiers</td>\n</tr>\n<tr>\n<td>Enzyme</td>\n<td>Allosteric inhibitor</td>\n<td>Allosteric activator</td>\n</tr>\n<tr>\n<td>1. ALA synthase</td>\n<td>Heme</td>\n<td>-</td>\n</tr>\n<tr>\n<td>2. Aspartate transcarbamoylase</td>\n<td>CTP</td>\n<td>ATP</td>\n</tr>\n<tr>\n<td>3. HMG CoA reductase</td>\n<td>Cholesterol</td>\n<td>-</td>\n</tr>\n<tr>\n<td>4.Phosphofructokinase</td>\n<td>Citrate, ATP</td>\n<td>AMP, F2,6P</td>\n</tr>\n<tr>\n<td>5. Acetyl CoA carboxylase</td>\n<td>Acyl CoA</td>\n<td>Citrate</td>\n</tr>\n<tr>\n<td>6. Citrate synthase</td>\n<td>ATP</td>\n<td>-</td>\n</tr>\n<tr>\n<td>7. Carbamoyl phosphate synthase-I</td>\n<td>-</td>\n<td>NAG</td>\n</tr>\n<tr>\n<td>8. Carbamoyl phosphate synthase-II</td>\n<td>ATP</td>\n<td>-</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/34fac50a7250488b88596ffb2c1141e5x1280x883.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1206",
      "difficulty": "medium"
    },
    {
      "text": "A 46-year-old male visits the cardiology clinic with a history of exertional chest pain. He is a known diabetic, hypertensive and hyperlipidemic which are controlled with appropriate medication. Considering his high 10 year-ASCVD risk score (atherosclerotic cardiovascular disease risk), he is started on low dose aspirin. Which of the following best defines the mechanism of aspirin action?",
      "choices": [
        {
          "id": 1,
          "text": "Suicide inhibition"
        },
        {
          "id": 2,
          "text": "Competitive inhibition"
        },
        {
          "id": 3,
          "text": "Allosteric activation"
        },
        {
          "id": 4,
          "text": "Allosteric inhibition"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Low dose aspirin</strong> exerts its action by irreversibly inhibiting <strong>cyclooxygenase enzyme</strong> activity in <strong>platelets</strong>, which is an example of <strong>suicide inhibition</strong>.</p>\n<p>A suicidal enzyme is one that undergoes <strong>self-destruction</strong> in order to terminate its own activity. In this case, in response to irreversible inhibition by aspirin, platelet cyclooxygenase loses its ability to synthesize <strong>thromboxane</strong>. It undergoes self-destruction. Unless new platelets are formed, this cyclooxygenase activity cannot be regained. </p><hr><h3>Related Pearl: Some Examples of Suicidal Inhibitors</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Suicidal Inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Enzyme</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Allopurinol</p>\n</td>\n<td>\n<p>Xanthine oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Cyclooxygenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5-Flurouracil</p>\n</td>\n<td>\n<p>Thymidylate synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Penicillin</p>\n</td>\n<td>\n<p>Transpeptidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>DFMO</p>\n</td>\n<td>\n<p>Ornithine Decarboxylase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1201",
      "difficulty": "medium"
    },
    {
      "text": "An adult male patient presents with yellow discolouration of the sclera. There was a history of recurrent mild jaundice since childhood. His lab values are mentioned below. A liver biopsy was performed which revealed normal liver architecture with coarse granular black pigmentation. The mutation of which protein is involved in the following condition?<div class='question-desc-html'><p>AST: 20 U/L , ALT: 18 U/L</p>\n<p>Total bilirubin : 4.2mg/dl, Conjugated bilirubin: 3.6 mg/dl</p>\n<p>Total protein: 6.4 g/dL, normal A/G ratio.</p>\n<p>Urine: Normal porphyrin levels.</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "OATP1B1"
        },
        {
          "id": 2,
          "text": "BSEP"
        },
        {
          "id": 3,
          "text": "MRP-3"
        },
        {
          "id": 4,
          "text": "MRP-2"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Yellow discolouration of the sclera with coarse granular black pigmentation of the liver is suggestive of <strong>Dubin–Johnson syndrome</strong>, characterized by a mutation in the<strong> MRP-2 </strong>protein.<strong><br /></strong></p>\n<p>Dubin–Johnson syndrome is an <strong>autosomal recessive</strong> disorder with predominantly<strong> conjugated hyperbilirubinemia</strong>. It is due to a defect in the <strong>active</strong> <strong>transport </strong>of <strong>bilirubin</strong> across the canalicular membrane, due to a mutation in the MRP-2 protein.<strong> </strong>It is also known as <strong>black liver jaundice</strong> due to the accumulation of a<strong> dark pigment</strong>,<strong> </strong>derived from epinephrine metabolites, in the lysosomes of <strong>centrilobular hepatocytes</strong>. <strong>Bromosulpthalein</strong> test on plasma shows 2 peaks.</p>\n<p>Option A: <strong>OATP1B1</strong> and<strong> OATP1B3</strong> are mutated in<strong> </strong>Rotor syndrome.<strong> </strong>It is due to defective bilirubin excretion and causes conjugated hyperbilirubinemia.</p>\n<p>Option B:<strong> BSEP</strong> protein is mutated in<strong> </strong>progressive familial intrahepatic cholestasis (PFIC type-2) and benign recurrent intrahepatic cholestasis (BRIC-2).</p>\n<p>Option C: <strong>MRP-3</strong> is mutated in<strong> </strong>PFIC type-3.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8518b44c87334f41b2aca086ef0d4abex1280x2025.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Hyperbilirubinemia- Causes</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Predominantly Unconjugated Hyperbilirubinemia&nbsp;</strong></td>\n<td><strong>Conjugated hyperbilirubinemia</strong></td>\n</tr>\n<tr>\n<td>\n<p>Excess production of bilirubin</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hemolytic anemias</p>\n</td>\n<td>\n<p>Biliary tract obstruction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Resorption of blood from internal hemorrhage (e.g., alimentary tract bleeding, hematomas)</p>\n</td>\n<td>\n<p>&nbsp;Biliary tract diseases like primary biliary cirrhosis and primary sclerosing cholangitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ineffective erythropoiesis (e.g., pernicious anemia, thalassemia)</p>\n</td>\n<td>\n<p>Dubin Johnson syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reduced hepatic uptake</p>\n</td>\n<td>\n<p>Rotor syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Drug interference with membrane carrier systems</p>\n</td>\n<td>Benign recurrent intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td>\n<p>Some cases of Gilbert syndrome</p>\n</td>\n<td>Progressive familial intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td>\n<p>Impaired bilirubin conjugation</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Physiologic jaundice of the newborn (decreased UGT1A1 activity, decreased excretion)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Breast milk jaundice (&beta;-glucuronidases in milk)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Genetic deficiency of UGT1A1 activity (Crigler-Najjar syndrome types I and II)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse hepatocellular disease (e.g., viral or drug-induced hepatitis, cirrhosis)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Hereditary Hyperbilirubinemias</h3><table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Defects in bilirubin metabolism</strong></td>\n<td><strong>Clinical course</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Unconjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type I</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Absent UGT1A1 activity</p>\n</td>\n<td>\n<p>Fatal in the neonatal period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type II</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Generally mild,</p>\n<p>occasional kernicterus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>\n<p>AR (common)</p>\n<p>AD (occasional)</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Conjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Dubin-Johnson syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Impaired biliary excretion of bilirubin glucuronides due to a mutation in canalicular multidrug resistance protein 2 (MRP2)</p>\n</td>\n<td>\n<p>Innocuous with black pigmentation of liver</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotor syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased hepatic uptake and storage</p>\n<p>Decreased biliary excretion</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0758",
      "difficulty": "medium"
    },
    {
      "text": "Which bond is catalyzed by amylase enzyme?",
      "choices": [
        {
          "id": 1,
          "text": "α(1 → 4) glycoside bonds"
        },
        {
          "id": 2,
          "text": "α(1 → 6) glycoside bonds"
        },
        {
          "id": 3,
          "text": "β (1 → 4) glycoside bonds"
        },
        {
          "id": 4,
          "text": "β(1 → 6) glycoside bonds"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>&alpha;(1 &rarr; 4) glycoside</strong> bonds are catalyzed by <strong>amylase</strong> enzymes.</p>\n<p>Starch is a polymer of glucose that is linked by&nbsp;<strong>&alpha;(1 &rarr; 4) glycoside</strong> bonds, which is&nbsp;<strong>catalyzed by salivary and pancreatic amylases.</strong></p>\n<p>Hydrolysis of starch yields dextrin.</p>\n<p>Then the hydrolysis of dextrin will yield a mixture of glucose, maltose, maltotriose, and small branched dextrins.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2843",
      "difficulty": "medium"
    },
    {
      "text": "Which enzyme  hydrolyzes peptide bonds between specific amino acids throughout the molecule?",
      "choices": [
        {
          "id": 1,
          "text": "Exopeptidases"
        },
        {
          "id": 2,
          "text": "Endopeptidases"
        },
        {
          "id": 3,
          "text": "Carboxypeptidases"
        },
        {
          "id": 4,
          "text": "Aminopeptidases"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Endopeptidases </strong>hydrolyze<strong> peptide bonds between specific amino acids </strong>throughout the molecule.</p>\n<p>They are the first enzymes to act, yielding a larger number of smaller fragments.</p>\n<p><strong>Examples of endopeptidases:</strong></p>\n<ul>\n<li>Trypsin&nbsp;</li>\n<li>Chymotrypsin&nbsp;</li>\n<li>Pepsin</li>\n<li>Elastase&nbsp;</li>\n<li>Thermolysin&nbsp;</li>\n<li>Glutamyl endopeptidase&nbsp;</li>\n<li>Neprilysin</li>\n</ul>\n<p><strong>Exopeptidases </strong>catalyze the hydrolysis of peptide bonds, one at a time, from the ends of peptides. There are two types of exopeptidase:</p>\n<div class=\"page\" title=\"Page 532\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><strong>Carboxypeptidases,</strong> secreted in the pancreatic juice, release amino acids from the free carboxyl-terminal end</li>\n<li><strong>Aminopeptidases,</strong> secreted by the intestinal mucosal cells, release amino acids from the amino-terminal</li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2853",
      "difficulty": "medium"
    },
    {
      "text": "Specific dynamic action is maximum for ______",
      "choices": [
        {
          "id": 1,
          "text": "Carbohydrates"
        },
        {
          "id": 2,
          "text": "Proteins"
        },
        {
          "id": 3,
          "text": "Lipids"
        },
        {
          "id": 4,
          "text": "Mixed Diet"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Specific dynamic action</strong> is <strong>maximum for proteins.</strong></p>\n<p>Specific dynamic action/diet-induced thermogenesis/ thermic effect of food is the extra energy needed by the body for digestion, absorption, and disposal of ingested nutrients.</p>\n<p><strong>Specific dynamic action</strong>&nbsp;magnitude depends on the composition of the food consumed:</p>\n<ul>\n<li>Carbohydrates: 5 to 15% of the energy consumed</li>\n<li>Fats: at most 5 to 15&nbsp;%</li>\n<li><strong>Protein: 20 to 35%&nbsp;</strong></li>\n</ul>\n<p>The energy generated by the metabolism of the macronutrients is used for<strong> three energy-requiring</strong> processes that occur in the body:</p>\n<ul>\n<li>Resting metabolic rate</li>\n<li>Thermic effect of food (formerly termed specific dynamic action)</li>\n<li>Physical activity</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2864",
      "difficulty": "medium"
    },
    {
      "text": "Basal metabolic rate is closely dependent on which of the following factors?",
      "choices": [
        {
          "id": 1,
          "text": "Body surface area"
        },
        {
          "id": 2,
          "text": "Lean body mass"
        },
        {
          "id": 3,
          "text": "Body mass index"
        },
        {
          "id": 4,
          "text": "Height to weight ratio"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Basal metabolic rate </strong>(BMR) is closely dependent on <strong>lean</strong> <strong>body</strong> <strong>mass</strong> (fat-free mass).</p>\n<p>Lean body mass is the difference between total body weight and body fat weight. It is the metabolically active tissue in the body.</p>\n<p>The <strong>BMR decreases</strong> with increasing <strong>age</strong>, even when body weight remains constant. This is the result of muscle tissue replacement by adipose tissue, which is metabolically less active. <strong>Women</strong> have a significantly <strong>lower</strong> <strong>BMR</strong> than men of the same body weight and age. This is because women’s bodies contain proportionally more adipose tissue.</p><hr><h3>Related Pearl: Basal Metabolic Rate</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>BMR is increased in</strong></p>\n</td>\n<td>\n<p><strong>BMR is decreased in</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fever</p>\n</td>\n<td>\n<p>Protein energy malnutrition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperthyroidism</p>\n</td>\n<td>\n<p>Hypothyroidism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cold environment</p>\n</td>\n<td>\n<p>Addison disease</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p>Cachexia</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Starvation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing&rsquo;s syndrome</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2870",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following fat-soluble vitamins also has coenzyme activity?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin A"
        },
        {
          "id": 2,
          "text": "Vitamin D"
        },
        {
          "id": 3,
          "text": "Vitamin E"
        },
        {
          "id": 4,
          "text": "Vitamin K"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The only <strong>fat-soluble vitamin</strong> that has a<strong> coenzyme </strong>function is<strong> vitamin K.</strong></p>\n<p>The co-enzyme role of vitamin K is in the <strong>γ-carboxylation </strong>reaction of <strong>clotting factors.</strong></p>\n<p>Many of the water-soluble vitamins also have a coenzyme function, such as:</p>\n<ul>\n<li><strong>Vitamin B1 </strong>as thiamine pyrophosphate (TPP)</li>\n<li><strong>Vitamin B6 </strong>as pyridoxal phosphate (PLP)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2925",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following multienzyme complexes catalyzing decarboxylation reactions does not require thiamine as a coenzyme?",
      "choices": [
        {
          "id": 1,
          "text": "Pyruvate dehydrogenase"
        },
        {
          "id": 2,
          "text": "α-ketoglutarate dehydrogenase"
        },
        {
          "id": 3,
          "text": "Branched-chain keto-acid dehydrogenase"
        },
        {
          "id": 4,
          "text": "Isocitrate dehydrogenase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Thiamine pyrophosphate</strong> (TPP) does not serve as the coenzyme for <strong>isocitrate dehydrogenase</strong>. </p>\n<p>Isocitrate dehydrogenase, an enzyme of the citric acid cycle, uses <strong>Mg<sup>2+</sup></strong> or <strong>Mn<sup>2+</sup></strong> ions as a coenzyme. </p>\n<p><strong>Thiamine</strong> pyrophosphate (TPP), from vitamin B1, serves as the coenzyme for three multienzyme complexes that catalyze oxidative decarboxylation reactions:</p>\n<ul>\n<li><strong>Pyruvate dehydrogenase</strong> - carbohydrate metabolism</li>\n<li><strong>α-ketoglutarate dehydrogenase</strong> - citric acid cycle</li>\n<li><strong>Branched-chain keto-acid dehydrogenase</strong> - metabolism of leucine, isoleucine, valine</li>\n</ul>\n<p>Most of these enzymes are involved in carbohydrate metabolism, so thiamine is required in excess during a high carbohydrate diet. TPP also serves as the cofactor for <strong>transketolase</strong> in the <strong>HMP shunt.</strong></p><hr><h3>Related Pearl: Active Forms and Functions of Water-Soluble Vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<p>Vitamin</p>\n</td>\n<td colspan=\"2\">\n<p>Coenzyme</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Name</p>\n</td>\n<td>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B1(Thiamin)</p>\n</td>\n<td>\n<p>Thiamine pyrophosphate (TPP)</p>\n</td>\n<td>\n<p>Decarboxylation</p>\n<p>Transketolase reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B2(Riboflavin)</p>\n</td>\n<td>\n<p>Flavin-adenine-dinucelotide (FAD)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B3(Nicotinic acid, niacin)</p>\n</td>\n<td>\n<p>Nicotinamide-adenine dinucleotide(NAD<sup>+</sup>)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B5(Pantothenic acid)</p>\n</td>\n<td>\n<p>Coenzyme A</p>\n</td>\n<td>\n<p>Transfer of an acyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B6(Pyridoxine)</p>\n</td>\n<td>\n<p>Pyridoxal Phosphate(PLP)</p>\n</td>\n<td>\n<p>Transamination</p>\n<p>Decarboxylation</p>\n<p>Co-factor of glycogen phosphorylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B7(Biotin)</p>\n</td>\n<td>\n<p>Biotin</p>\n</td>\n<td>\n<p>Carboxylation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B9(Folic acid)</p>\n</td>\n<td>\n<p>Tetrahydrofolic acid (THFA)</p>\n</td>\n<td>\n<p>Donor of methyl/formyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B12(Cobalamin)</p>\n</td>\n<td>\n<p>Methylcobalamin and Adenosylcobalamin</p>\n</td>\n<td>\n<p>Co-factor of methionine synthase and methylmalonyl CoA mutase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C (Ascorbic acid)</p>\n</td>\n<td>Ascorbic acid and dehydroascorbic acid</td>\n<td>\n<p>Oxidation-reduction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3054",
      "difficulty": "medium"
    },
    {
      "text": "FMN and FAD coenzymes are derived from which of the following vitamin?",
      "choices": [
        {
          "id": 1,
          "text": "Niacin"
        },
        {
          "id": 2,
          "text": "Vitamin B1"
        },
        {
          "id": 3,
          "text": "Riboflavin"
        },
        {
          "id": 4,
          "text": "Vitamin B5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Coenzymes<strong> flavin mononucleotide</strong> (FMN)<strong> </strong>and <strong>flavin adenine dinucleotide</strong> (FAD) are derived from <strong>riboflavin </strong>(vitamin B2).</p>\n<p>FMN-coenzyme is part of <strong>complex I</strong> (also known as NADH-Q oxidoreductase, NADH dehydrogenase) in <strong>electron transport chain </strong>(ETC).  It also acts as a coenzyme for <strong>L-amino acid oxidase. </strong></p>\n<p>FAD-coenzyme is part of <strong>complex II</strong> in ETC. It acts as a coenzyme for <strong>succinate dehydrogenase </strong>(Kreb's cycle), <strong>acyl CoA dehydrogenase</strong> (fatty acid oxidation), <strong>D-amino acid oxidase</strong> and <strong>xanthine oxidase</strong>. </p><hr><h3>Related Pearl: Active Forms and Functions of Water-Soluble Vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<p>Vitamin</p>\n</td>\n<td colspan=\"2\">\n<p>Coenzyme</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Name</p>\n</td>\n<td>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B1(Thiamin)</p>\n</td>\n<td>\n<p>Thiamine pyrophosphate (TPP)</p>\n</td>\n<td>\n<p>Decarboxylation</p>\n<p>Transketolase reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B2(Riboflavin)</p>\n</td>\n<td>\n<p>Flavin-adenine-dinucelotide (FAD)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B3(Nicotinic acid, niacin)</p>\n</td>\n<td>\n<p>Nicotinamide-adenine dinucleotide(NAD<sup>+</sup>)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B5(Pantothenic acid)</p>\n</td>\n<td>\n<p>Coenzyme A</p>\n</td>\n<td>\n<p>Transfer of an acyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B6(Pyridoxine)</p>\n</td>\n<td>\n<p>Pyridoxal Phosphate(PLP)</p>\n</td>\n<td>\n<p>Transamination</p>\n<p>Decarboxylation</p>\n<p>Co-factor of glycogen phosphorylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B7(Biotin)</p>\n</td>\n<td>\n<p>Biotin</p>\n</td>\n<td>\n<p>Carboxylation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B9(Folic acid)</p>\n</td>\n<td>\n<p>Tetrahydrofolic acid (THFA)</p>\n</td>\n<td>\n<p>Donor of methyl/formyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B12(Cobalamin)</p>\n</td>\n<td>\n<p>Methylcobalamin and Adenosylcobalamin</p>\n</td>\n<td>\n<p>Co-factor of methionine synthase and methylmalonyl CoA mutase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C (Ascorbic acid)</p>\n</td>\n<td>Ascorbic acid and dehydroascorbic acid</td>\n<td>\n<p>Oxidation-reduction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3057",
      "difficulty": "easy"
    },
    {
      "text": "Vitamin B6 nutritional status is assessed by monitoring the activity of ______",
      "choices": [
        {
          "id": 1,
          "text": "RBC transketolase"
        },
        {
          "id": 2,
          "text": "RBC transaminase"
        },
        {
          "id": 3,
          "text": "Pyruvate dehydrogenase"
        },
        {
          "id": 4,
          "text": "Isocitrate dehydrogenase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most widely used method to know <strong>the vitamin B6 nutritional status,</strong> is by <strong>measuring</strong> the&nbsp;<strong>RBC transaminase activity</strong>, by adding pyridoxal phosphate in vitro.</p>\n<p>The direct measurement of the plasma concentrations of the vitamin(pyridoxal phosphate) can also be done.</p><hr><h3>Related Pearl: Biochemical Assay for Vitamin Deficiency State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Assay and test</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B1 (Thiamine)</p>\n</td>\n<td>\n<p>RBC Trans-ketolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B2 (Riboflavin)</p>\n</td>\n<td>\n<p>RBC glutathione reductase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 (Pyridoxine)</p>\n</td>\n<td>\n<p>RBC transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B9 (Folic acid)</p>\n</td>\n<td>\n<p>FIGLU excretion/Histidine load test</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B12 (Cobalamine)</p>\n</td>\n<td>\n<p>Serum methyl malonate level</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3064",
      "difficulty": "medium"
    },
    {
      "text": "A farmer presents with loose stools, depression, and photosensitive dermatitis as shown in the image. On examination, a red beefy tongue is noted. Which of the following is not associated with this presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Hartnup disease"
        },
        {
          "id": 2,
          "text": "Carcinoid syndrome"
        },
        {
          "id": 3,
          "text": "Wernicke's encephalopathy"
        },
        {
          "id": 4,
          "text": "Pyridoxine deficiency"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Loose stools, depression, beefy red tongue and Casal's necklace, as seen in the image, is suggestive of <strong>pellagra.</strong> Pellagra-like symptoms are<strong> not seen</strong> in<strong> Wernicke's encephalopathy</strong>.</p>\n<p>Pellagra is caused by niacin deficiency, either due to<strong> dietary deficiency</strong> or <strong>deficient conversion</strong> of tryptophan to niacin. Hence, pellagra-like symptoms are seen in:</p>\n<ul>\n<li><strong>Hartnup disease:</strong> It is an <strong>a</strong><strong>utosomal recessive</strong> disease<strong> </strong>caused by mutations in the <em>SLC6A19</em> gene leading to defective membrane transport of tryptophan across PCT (kidney) and enterocytes (intestine). This leads to malabsorption, and hence deficiency of tryptophan.</li>\n<li><strong>Carcinoid syndrome:</strong> Due to excess conversion of tryptophan to serotonin, there is a decreased level of tryptophan availavle for niacin synthesis</li>\n<li><strong>Pyridoxine deficiency:</strong> Pyridoxine is required as the co-factor of <strong>kynureninase</strong>, an enzyme in the pathway of niacin synthesis.</li>\n<li><strong>Maize/corn rich diet</strong>: In these grans, niacin is in bound form (niacytin form) and is not absorbed.</li>\n<li><strong>Jowar diet </strong>(Sorghum): The increased leucine content inhibits QPRTase enzyme, an enzyme in the pathway of niacin synthesis. </li>\n</ul><hr><h3>Related Pearl: Conditions Associated with Pellagra-like Symptoms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition/Disease</strong></p>\n</td>\n<td>\n<p><strong>Reason for niacin deficiency</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hartnup disease</p>\n</td>\n<td>\n<p>Intestinal &amp; renal malabsorption of tryptophan</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoid syndrome</p>\n</td>\n<td>\n<p>Overproduction of serotonin that causes diversion of  tryptophan from NAD+ Pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 deficiency</p>\n</td>\n<td>\n<p>Defective kynureninase pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maize rich diet</p>\n</td>\n<td>\n<p>Niacin is in unavailable niacytin form</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Jowar diet (Sorghum)</p>\n</td>\n<td>\n<p>Increase leucine content inhibit QPRTase enzyme</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/20f0c68170c2437a8e235efe8000eed6.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3266",
      "difficulty": "easy"
    },
    {
      "text": "Hartnup’s disease causes a deficiency of _______",
      "choices": [
        {
          "id": 1,
          "text": "Thiamine"
        },
        {
          "id": 2,
          "text": "Riboflavin"
        },
        {
          "id": 3,
          "text": "Niacin"
        },
        {
          "id": 4,
          "text": "Biotin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<ul>\n<li><strong>Hartnup&rsquo;s disease</strong> causes a <strong>deficiency</strong> state <strong>of</strong> <strong>niacin.<br /></strong></li>\n<li>It is <strong>Autosomal recessive&nbsp;</strong>caused by mutations in the<strong> <em>SLC6A19</em> gene.</strong></li>\n<li>It is characterized by impaired absorption of the amino acid tryptophan.</li>\n<li>As a result of the reduced levels of tryptophan, there is <strong>lesser conversion to niacin</strong>. This leads to a state of niacin deficiency.</li>\n</ul><hr><h3>Related Pearl: Conditions Associated with Pellagra-like Symptoms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition/Disease</strong></p>\n</td>\n<td>\n<p><strong>Reason for niacin deficiency</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hartnup disease</p>\n</td>\n<td>\n<p>Intestinal &amp; renal malabsorption of tryptophan</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoid syndrome</p>\n</td>\n<td>\n<p>Overproduction of serotonin that causes diversion of  tryptophan from NAD+ Pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 deficiency</p>\n</td>\n<td>\n<p>Defective kynureninase pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maize rich diet</p>\n</td>\n<td>\n<p>Niacin is in unavailable niacytin form</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Jowar diet (Sorghum)</p>\n</td>\n<td>\n<p>Increase leucine content inhibit QPRTase enzyme</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3268",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following method is not used for the measurement of body free radical burden?",
      "choices": [
        {
          "id": 1,
          "text": "Ferrous oxidation in xylenol assay"
        },
        {
          "id": 2,
          "text": "Measurement of pentane and methane in exhaled air"
        },
        {
          "id": 3,
          "text": "Estimation of dialdehydes"
        },
        {
          "id": 4,
          "text": "Direct assay of free radicals"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 429\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Direct assay</strong> of free radicals is <strong>not used</strong> for the measurement of total body free radical burden.</p>\n<p>This is because free radicals are extremely <strong>reactive</strong> and <strong>short-lived</strong>. <strong>Free radical</strong> activity is usually <strong>assessed</strong> by <strong>indirect methods. </strong>Thus, the total body<strong> free</strong> <strong>radical burden</strong> can be estimated by <strong>measuring</strong> the<strong> products</strong> of<strong> lipid peroxidation </strong>using the following methods:</p>\n<ul>\n<li>FOX (Ferrous oxidation in xylenol orange) assay</li>\n<li>Estimation of dialdehydes: The dialdehydes formed from lipid peroxides can be measured by reaction with thiobarbituric acid.</li>\n<li>Measurement of pentane and methane in exhaled air</li>\n</ul>\n<div class=\"page\" title=\"Page 429\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 429\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Note</strong>: Radical damage to unsaturated fatty acids in cell membranes and plasma lipoproteins leads to the formation of<strong> lipid peroxides.</strong></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3280",
      "difficulty": "medium"
    },
    {
      "text": "Zinc is a cofactor of which of the following enzymes?",
      "choices": [
        {
          "id": 1,
          "text": "Xanthine oxidase"
        },
        {
          "id": 2,
          "text": "Glutathione peroxidase"
        },
        {
          "id": 3,
          "text": "Carbonic anhydrase"
        },
        {
          "id": 4,
          "text": "Lysyl oxidase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Zinc</strong> acts as a <strong>cofactor</strong> for <strong>carbonic anhydrase.</strong></p>\n<p>Zinc is a component of many <strong>metalloenzymes</strong> including carbonic anhydrase II. Zinc also has <strong>antioxidant activity</strong> as extracellular superoxide dismutase is zinc-dependent.</p>\n<p><strong>Chronic zinc deficiency </strong>can cause <strong>stunted growth</strong>,<strong> hypogeusia</strong> (decreased taste sensation) hypogeusia, <strong>impaired immune function</strong>, <strong>hypogonadism </strong>and<strong> </strong>hypopigmented hair. <strong>Acrodermatitis enteropathica</strong> is an autosomal recessive disorder characterized by abnormalities in zinc absorption.</p><hr><h3>Related Pearl: Metals as cofactors and prosthetic groups in enzymes</h3><table>\n<tbody>\n<tr>\n<td><strong>Metal</strong></td>\n<td><strong> Enzymes</strong></td>\n</tr>\n<tr>\n<td>Zinc</td>\n<td>\n<ul>\n<li>Carbonic anhydrase II</li>\n<li>Carboxypeptidase A</li>\n<li>Alcohol dehydrogenase</li>\n<li>Alkaline phosphatase</li>\n<li>ALA dehydratase</li>\n<li>Lactate dehydrogenase</li>\n<li>Adenosine deaminase</li>\n<li>Phospholipase C</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Selenium</td>\n<td>\n<p> </p>\n<ul>\n<li>Glutathione peroxidase</li>\n<li>Thioredoxin reductase</li>\n<li>De-iodinase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Magnesium</td>\n<td>\n<ul>\n<li>Phosphofructokinase</li>\n<li>Hexokinase</li>\n<li>Glucose -6-phosphatase</li>\n<li>Mutase</li>\n<li>Enolase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Copper</td>\n<td>\n<ul>\n<li>Cytosolic superoxide dismutase</li>\n<li>Tyrosinase</li>\n<li>Cyt c oxidase</li>\n<li>Lysyl oxidase</li>\n<li>Amino acid oxidase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Molybdenum</td>\n<td>\n<ul>\n<li>Dinitrogenase</li>\n<li>Xanthine oxidase</li>\n<li>Sulfite oxidase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Manganese</td>\n<td>\n<ul>\n<li>Mitochondrial superoxide dismutase</li>\n<li>Enolase</li>\n<li>Arginase</li>\n<li>Hexokinase</li>\n<li>Phosphofructokinase</li>\n<li>Ribonucleotide reductase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Iron</td>\n<td>\n<ul>\n<li>Succinate Dehydrogenase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium</td>\n<td>\n<ul>\n<li>Lipase</li>\n<li>Lecithinase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Nickel</td>\n<td>\n<ul>\n<li>   Urease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6885",
      "difficulty": "medium"
    },
    {
      "text": "A 10-year-old girl is brought to the dermatologist by her parents. She has many freckles on her face and limbs as shown below. She is also unusually sensitive to sunlight. Early changes of squamous cell carcinomas are also noted on her face. Which of the following processes is most like to be defective in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Defective DNA nucleotide excision repair"
        },
        {
          "id": 2,
          "text": "Defective DNA base excision repair"
        },
        {
          "id": 3,
          "text": "Defective DNA mismatch repair"
        },
        {
          "id": 4,
          "text": "Defective homologous repair"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Photosensitivity, freckling and skin cancer on the face in a child aare suggestive of <strong>xeroderma pigmentosum</strong>. It is an example of <strong>defective DNA nucleotide excision repair. </strong></p>\n<p>In xeroderma pigmentosum, there is an inability<span class=\"fontstyle0\"> to <strong>repair DNA pyrimidine dimers</strong> caused by UV exposure. </span><span>It is an autosomal recessive disease characterized by </span><strong>exaggerated sunburns</strong><span> and pigmentary changes on exposure to UV radiations. There is </span><strong>increased risk</strong><span> of developing non-melanoma and melanoma </span><strong>skin cancers</strong><span>, and </span><strong>neurodegeneration</strong><span>. They are also more prone to developing smoking-induced lung cancers.  </span></p>\n<p><span>Diagnosis is mainly clinical and it can be confirmed definitively by </span><strong>cellular tests</strong><span> for defective DNA repair. </span><span>Management includes </span><strong>sun avoidance</strong><span> and regular follow-up to assess and treat any skin cancers. There is </span><strong>no cure</strong><span> for xeroderma pigmentosum.</span></p><hr><h3>Related Pearl: Human Diseases of DNA Damage Repair</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>DNA damage repair type</strong></p>\n</td>\n<td>\n<p><strong>Diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Nonhomologous End Joining Repair (NHEJ)</p>\n</td>\n<td>\n<p>Severe combined immunodeficiency disease (SCID)</p>\n<p>Radiation sensitive severe combined immunodeficiency disease(RS-SCID)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Homologous Repair (HR)</p>\n</td>\n<td>\n<p>AT-like disorder (ATLD)</p>\n<p>Nijmegen breakage syndrome (NBS)</p>\n<p>Bloom syndrome (BS)</p>\n<p>Werner syndrome (WS)</p>\n<p>Rothmund-Thomson syndrome (RTS)</p>\n<p>Breast cancer suspectibility 1 and 2 (BRCA1, BRCA2)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Nucleotide Excision Repair (NER)</p>\n</td>\n<td>\n<p>Xeroderma pigmentosum (XP)</p>\n<p>Cockayne syndrome (CS)</p>\n<p>Trichothiodystrophy (TTD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Base Excision Repair (BER)</p>\n</td>\n<td>\n<p>MUTYH-associated polyposis (MAP)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Mismatch Repair (MMR)</p>\n</td>\n<td>\n<p>Hereditary nonpolyposis colorectal cancer (HNPCC)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b27b5ac0ca26405dbd418d075890cdce.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2397",
      "difficulty": "easy"
    },
    {
      "text": "In SCID, what type of DNA repair is defective:",
      "choices": [
        {
          "id": 1,
          "text": "Base excision repair"
        },
        {
          "id": 2,
          "text": "Nucleotide excision repair"
        },
        {
          "id": 3,
          "text": "Mismatch Repair"
        },
        {
          "id": 4,
          "text": "Non-homologous end joining repair"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>SCID</strong> is due to defective <strong>non-homologous end joining repair</strong>.</p>\n<p><strong>Defects in DNA Repair:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Non-Homologous End Joining Repair</strong></td>\n<td>Severe combined immunodeficiency disease (SCID)</td>\n</tr>\n<tr>\n<td><strong>Homologous Repair</strong></td>\n<td>Bloom syndrome Werner syndrome Breast cancer susceptibility</td>\n</tr>\n<tr>\n<td><strong>Nucleotide Excision Repair</strong></td>\n<td>Xeroderma pigmentosum</td>\n</tr>\n<tr>\n<td><strong>Mismatch Repair</strong></td>\n<td>Hereditary nonpolyposis colorectal cancer (HNPCC)</td>\n</tr>\n<tr>\n<td><strong>Base Excision Repair</strong></td>\n<td>\n<p class=\"textbox\" dir=\"ltr\">MUTYH-associated polyposis (MAP)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9199",
      "difficulty": "medium"
    },
    {
      "text": "Which protein is produced by a regulatory gene?",
      "choices": [
        {
          "id": 1,
          "text": "Operon"
        },
        {
          "id": 2,
          "text": "Inducer"
        },
        {
          "id": 3,
          "text": "Promoter"
        },
        {
          "id": 4,
          "text": "Repressor"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A <strong>repressor protein</strong> is produced by a<strong> regulatory gene</strong>.</p>\n<p>In bacterial operons, a <strong>regulatory gene</strong>,<strong> </strong>like the <strong>lac</strong> <strong>I</strong> gene, which is present upstream of a set of structural genes, <strong>codes </strong>for a <strong>repressor protein</strong> (a transacting factor). The repressor protein binds to the <strong>operator </strong>site and interferes with the progress of RNA polymerase. This blocks transcription of the structural genes and is an example of <strong>negative regulation </strong>of gene transcription.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9e86086e09284a7eaa24d79a49175a8fx719x599.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2776",
      "difficulty": "medium"
    },
    {
      "text": "The lactose operon is likely to be transcribed when ______",
      "choices": [
        {
          "id": 1,
          "text": "There is more glucose in the cell than lactose"
        },
        {
          "id": 2,
          "text": "Cyclic AMP levels are low"
        },
        {
          "id": 3,
          "text": "There is glucose but no lactose in the cell"
        },
        {
          "id": 4,
          "text": "Cyclic AMP and lactose levels are both high within the cell"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The lac operon is induced only when <strong>cyclic AMP </strong>and <strong>lactose levels </strong>are<strong> both high </strong>within the cell.</p>\n<p>When lactose is present in abundance, a small amount of lactose is converted to <strong>allolactose.</strong> This compound<strong> binds</strong> to the <strong>repressor protein</strong> of the lac operon and creates a <strong>conformational change</strong>. As a result, the repressor cannot bind to the operator and <strong>transcription</strong> of the structural genes occurs. This is an example of <strong>negative regulation</strong>.</p>\n<p>This can only occur when <strong>glucose</strong> is <strong>absent</strong>. In the absence of glucose, <strong>adenylyl cyclase </strong>is active. This generates sufficient quantities of<strong> cAMP</strong> which bind to <strong>catabolite activator protein</strong> (CAP).The <strong>cAMP–CAP trans-acting complex</strong> binds to the <strong>CAP-binding site</strong>, another regulatory region present upstream of the structural genes of the operon. This causes RNA polymerase to more efficiently initiate transcription at the promoter site. This is an example of<strong> positive regulation</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d6336c3c3fd44b9590451a9c80459952x719x599.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2779",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following cloning vectors has linear DNA?",
      "choices": [
        {
          "id": 1,
          "text": "Phages"
        },
        {
          "id": 2,
          "text": "Plasmid"
        },
        {
          "id": 3,
          "text": "Cosmid"
        },
        {
          "id": 4,
          "text": "All of above"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Phages</strong> have <strong>linear </strong>DNA into which <strong>foreign DNA</strong> can be inserted at several <strong>restriction enzyme sites.</strong></p>\n<p>Amplification of DNA (cloning) is done using cloning vectors - bacterial <strong>plasmids, phages,</strong> or <strong>cosmids.</strong></p>\n<p><strong>Bacterial plasmids</strong> are small, <strong>circular,</strong> duplex DNA molecules whose natural function is to confer <strong>antibiotic resistance</strong> to the host cell. <strong>Cosmid</strong> is a plasmid into which the DNA sequences from <strong>bacteriophage lambda</strong> (λ <em>cos</em> sites) have been inserted. This enables the packaging of plasmid DNA in vitro. They have a small, <strong>circular,</strong> duplex DNA. (Options B and C)</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2805",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the best screening investigation for metabolic disorders?",
      "choices": [
        {
          "id": 1,
          "text": "Western blot"
        },
        {
          "id": 2,
          "text": "Tandem mass spectrometry"
        },
        {
          "id": 3,
          "text": "PCR"
        },
        {
          "id": 4,
          "text": "Gel electrophoresis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Tandem mass spectrometry</strong> (MS) is the technique of choice for <strong>screening neonates</strong> for <strong>inherited metabolic diseases.</strong></p>\n<p>Tandem MS employs the equivalent of two mass spectrometers linked in series (MS-MS or MS2). It can be used to screen blood samples from newborns for the presence and concentrations of amino acids, fatty acids, and other metabolites.</p>\n<p><strong>Abnormalities in metabolite levels</strong> indicate inherited<strong> metabolic diseases</strong>, such as phenylketonuria, ethylmalonic encephalopathy, and glutaric acidemia type 1.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5240",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following diseases is an example of point mutation?",
      "choices": [
        {
          "id": 1,
          "text": "Hemoglobin Lepore"
        },
        {
          "id": 2,
          "text": "β-Thalassemia type III"
        },
        {
          "id": 3,
          "text": "Diabetes"
        },
        {
          "id": 4,
          "text": "Sickle cell disease"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Sickle cell disease</strong> is caused by a point mutation. </p>\n<p>This is caused by mutation of a single base out of the 3 × 10<sup>9</sup> in the genome, a <strong>T-to-A</strong> DNA substitution, resulting in an <strong>A-to-U</strong> change in the <strong>mRNA</strong> corresponding to the <strong>sixth codon</strong> of the β-globin gene.</p>\n<p>Defective production of β-globin results in a variety of diseases and is due to many different lesions in and around the β-globin gene.</p><hr><h3>Related Pearl: Structural Alterations of the β -Globin Gene</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Alteration</p>\n</td>\n<td>\n<p>Function affected</p>\n</td>\n<td>\n<p>Disease</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"4\">\n<p>Point Mutation</p>\n</td>\n<td>\n<p>Protein folding</p>\n</td>\n<td>\n<p>Sickle cell disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Transcriptional control</p>\n</td>\n<td>\n<p>&beta;-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Frameshift &amp; nonsense mutations</p>\n</td>\n<td>\n<p>&beta;-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>RNA processing</p>\n</td>\n<td>\n<p>&beta;-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deletion</p>\n</td>\n<td>\n<p>mRNA production</p>\n</td>\n<td>\n<p>&beta;<sup>0</sup>-Thalassemia</p>\n<p>Hemoglobin Lepore</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rearrangement</p>\n</td>\n<td>\n<p>mRNA production</p>\n</td>\n<td>\n<p>&beta;-Thalassemia type III</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2824",
      "difficulty": "easy"
    },
    {
      "text": "The best method to measure HbA1C is ________",
      "choices": [
        {
          "id": 1,
          "text": "Isoelectric focusing"
        },
        {
          "id": 2,
          "text": "Affinity chromatography"
        },
        {
          "id": 3,
          "text": "Ion exchange chromatography"
        },
        {
          "id": 4,
          "text": "Electrophoresis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The best method to measure <strong>HBA1C</strong> is<strong> ion-exchange chromatography</strong>.</p>\n<p>In ion-exchange chromatography:</p>\n<ul>\n<li>Proteins interact with the <strong>stationary phase</strong> by <strong>charge-charge interactions.</strong></li>\n<li>Proteins with a net positive charge at a given pH will tightly adhere to beads with negatively charged functional groups such as carboxylates or sulfates (<strong>cation exchangers</strong>).</li>\n<li>Proteins with a net negative charge adhere to beads with positively charged functional groups, typically tertiary or quaternary amines (<strong>anion exchangers</strong>).</li>\n<li><strong>Non-adherent proteins</strong> flow through the matrix and are <strong>washed away</strong>.</li>\n<li>Proteins elute in inverse order of the strength of their interactions with the stationary phase.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5242",
      "difficulty": "medium"
    },
    {
      "text": "Identify the true statement regarding the regulation of the rate-limiting enzyme in de novo purine synthesis.<div class='question-desc-html'><p>ATP - Adenosine triphosphate</p>\n<p>GMP - Guanosine monophosphate</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Activated by glutamine analogs"
        },
        {
          "id": 2,
          "text": "Inhibited by ATP"
        },
        {
          "id": 3,
          "text": "Activated by GMP"
        },
        {
          "id": 4,
          "text": "Inhibited by GMP"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>rate-limiting</strong> enzyme in de novo purine synthesis is <strong>phosphoribosylpyrophosphate (PRPP) glutamyl amidotransferase; </strong>it is <strong>inhibited</strong> by <strong>GMP</strong> which is one of the end products of the pathway &amp; <strong>activated </strong>by the concentration of <strong>glutamine.</strong></p>\n<p>De novo purine synthesis involves the synthesis of purines from amphibolic intermediates. The <strong>first step</strong> of this reaction involves the transfer of two phosphoryl groups from ATP to ribose-5-phosphate form <strong>5-phosphoribosyl-1-pyrophosphate</strong> (PRPP), catalyzed by the enzyme <strong>PRPP synthase</strong>. PRPP is then converted to <strong>5-phosphoribosylamine</strong> by the enzyme <strong>PRPP glutamyl amidotransferase</strong>, in the presence of <strong>glutamine</strong> and H<sub>2</sub>O; this undergoes a series of changes to form <strong>inosine monophosphate</strong> (IMP).</p>\n<p>The IMP formed can then be used for the <strong>synthesis </strong>of both <strong>AMP</strong> and <strong>GMP</strong> by different pathways. Subsequently, one ATP is used for the conversion of AMP to ADP and GMP to GDP; this is followed by the synthesis of GTP from GDP using another phosphoryl group from ATP, while ADP can be converted to ATP by oxidative phosphorylation.</p>\n<p>The rate of the reaction is determined by the intracellular concentration of PRPP, which in turn depends on the rate of PRPP synthesis and utilization. The rate of PRPP synthesis depends on the availability of ribose-5-phosphate and on the activity of PRPP synthase, an enzyme whose activity is feedback inhibited by AMP, ADP, GMP, and GDP. Additionally, the enzyme <strong>PRPP glutamyl amidotransferase</strong> is <strong>inhibited</strong> by <strong>AMP</strong> and <strong>GMP</strong>, the end products of the pathway.</p>\n<p>The other compounds that <strong>block purine biosynthesis</strong> include <strong>azaserine</strong>, <strong>6-mercaptopurine</strong>, <strong>methotrexate</strong> and <strong>mycophenolic acid</strong>.</p><hr><h3>Related Pearl: Enzymes of Purine Synthesis Pathway and Their Regulators</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p><strong>Regulators</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PRPP Glutamyl Amidotransferase</p>\n</td>\n<td>\n<p>Inhibited by Amp &amp; GMP</p>\n<p>Activator &nbsp;PRPP</p>\n<p>Activated by Glutamine</p>\n<p>Diazanorleucine(inhibitor)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PRPP synthetase</p>\n</td>\n<td>\n<p>Activator pi</p>\n<p>Inhibitors &nbsp;purine ribonucleotides</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Formyltransferase</p>\n</td>\n<td>\n<p>Methotrexate, Anti-folate drugs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VI Synthetase</p>\n</td>\n<td>\n<p>Azaserine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adenylosuccinase ,IMP Dehydrogenase</p>\n</td>\n<td>\n<p>6-mercaptopurine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IMP Dehydrogenase</p>\n</td>\n<td>\n<p>mycophenolic acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2339",
      "difficulty": "medium"
    }
  ]
}